WO2022178444A1 - Dental adhesives formulated with secondary methacrylamides - Google Patents
Dental adhesives formulated with secondary methacrylamides Download PDFInfo
- Publication number
- WO2022178444A1 WO2022178444A1 PCT/US2022/017365 US2022017365W WO2022178444A1 WO 2022178444 A1 WO2022178444 A1 WO 2022178444A1 US 2022017365 W US2022017365 W US 2022017365W WO 2022178444 A1 WO2022178444 A1 WO 2022178444A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hemam
- methyl
- group
- hema
- dental adhesive
- Prior art date
Links
- 239000003479 dental cement Substances 0.000 title claims abstract description 62
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical group CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 title abstract description 76
- 239000000203 mixture Substances 0.000 claims abstract description 141
- 239000000178 monomer Substances 0.000 claims abstract description 140
- 150000001875 compounds Chemical class 0.000 claims description 44
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 27
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 claims description 25
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 9
- SAPGBCWOQLHKKZ-UHFFFAOYSA-N 6-(2-methylprop-2-enoyloxy)hexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCOC(=O)C(C)=C SAPGBCWOQLHKKZ-UHFFFAOYSA-N 0.000 claims description 8
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 6
- MKVYSRNJLWTVIK-UHFFFAOYSA-N ethyl carbamate;2-methylprop-2-enoic acid Chemical compound CCOC(N)=O.CC(=C)C(O)=O.CC(=C)C(O)=O MKVYSRNJLWTVIK-UHFFFAOYSA-N 0.000 claims description 4
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 claims description 3
- ICBJBNAUJWZPBY-UHFFFAOYSA-N 2-hydroxyethyl 3-methylbut-2-enoate Chemical compound CC(=CC(=O)OCCO)C ICBJBNAUJWZPBY-UHFFFAOYSA-N 0.000 claims description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
- LCFVJGUPQDGYKZ-UHFFFAOYSA-N Bisphenol A diglycidyl ether Chemical compound C=1C=C(OCC2OC2)C=CC=1C(C)(C)C(C=C1)=CC=C1OCC1CO1 LCFVJGUPQDGYKZ-UHFFFAOYSA-N 0.000 claims description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 3
- 239000005977 Ethylene Substances 0.000 claims description 3
- 241001130524 Hedma Species 0.000 claims description 3
- QUZSUMLPWDHKCJ-UHFFFAOYSA-N bisphenol A dimethacrylate Chemical class C1=CC(OC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OC(=O)C(C)=C)C=C1 QUZSUMLPWDHKCJ-UHFFFAOYSA-N 0.000 claims description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 3
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 3
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims description 3
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 claims description 3
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims description 3
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 claims 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 abstract description 31
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 91
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 79
- 238000006116 polymerization reaction Methods 0.000 description 63
- 238000005809 transesterification reaction Methods 0.000 description 47
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 40
- 230000007062 hydrolysis Effects 0.000 description 39
- 238000006460 hydrolysis reaction Methods 0.000 description 39
- 238000006243 chemical reaction Methods 0.000 description 38
- 230000009257 reactivity Effects 0.000 description 33
- 150000001408 amides Chemical group 0.000 description 32
- 239000000463 material Substances 0.000 description 32
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 32
- -1 vinyl amide radical Chemical class 0.000 description 32
- 229920000642 polymer Polymers 0.000 description 30
- 210000004268 dentin Anatomy 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- 230000000694 effects Effects 0.000 description 23
- 238000009472 formulation Methods 0.000 description 23
- 239000000047 product Substances 0.000 description 23
- 230000015556 catabolic process Effects 0.000 description 22
- 238000006731 degradation reaction Methods 0.000 description 22
- 239000005548 dental material Substances 0.000 description 22
- VNQXSTWCDUXYEZ-UHFFFAOYSA-N 1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione Chemical compound C1CC2(C)C(=O)C(=O)C1C2(C)C VNQXSTWCDUXYEZ-UHFFFAOYSA-N 0.000 description 21
- 229930006711 bornane-2,3-dione Natural products 0.000 description 21
- 238000006467 substitution reaction Methods 0.000 description 20
- KWVGIHKZDCUPEU-UHFFFAOYSA-N 2,2-dimethoxy-2-phenylacetophenone Chemical compound C=1C=CC=CC=1C(OC)(OC)C(=O)C1=CC=CC=C1 KWVGIHKZDCUPEU-UHFFFAOYSA-N 0.000 description 19
- 239000000126 substance Substances 0.000 description 19
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 description 18
- 230000001965 increasing effect Effects 0.000 description 18
- 150000002148 esters Chemical group 0.000 description 17
- 239000000853 adhesive Substances 0.000 description 16
- 230000001070 adhesive effect Effects 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 230000002829 reductive effect Effects 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 14
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 14
- 238000003860 storage Methods 0.000 description 14
- 230000000153 supplemental effect Effects 0.000 description 14
- BVQVLAIMHVDZEL-UHFFFAOYSA-N 1-phenyl-1,2-propanedione Chemical compound CC(=O)C(=O)C1=CC=CC=C1 BVQVLAIMHVDZEL-UHFFFAOYSA-N 0.000 description 13
- 229910052799 carbon Inorganic materials 0.000 description 12
- 230000009467 reduction Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 10
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 10
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 10
- 239000013000 chemical inhibitor Substances 0.000 description 10
- 239000007857 degradation product Substances 0.000 description 10
- 238000006317 isomerization reaction Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 9
- CUKVGYQSIHWKAV-UHFFFAOYSA-N 2-methylprop-2-enamide;2-methylprop-2-enoic acid Chemical compound CC(=C)C(N)=O.CC(=C)C(O)=O CUKVGYQSIHWKAV-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 8
- 241000183024 Populus tremula Species 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 239000003999 initiator Substances 0.000 description 8
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 8
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 8
- 239000003505 polymerization initiator Substances 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 238000001179 sorption measurement Methods 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 8
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 7
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 7
- KIMKGBGMXUPKJT-UHFFFAOYSA-N [diethyl-(4-methoxybenzoyl)germyl]-(4-methoxyphenyl)methanone Chemical compound C=1C=C(OC)C=CC=1C(=O)[Ge](CC)(CC)C(=O)C1=CC=C(OC)C=C1 KIMKGBGMXUPKJT-UHFFFAOYSA-N 0.000 description 7
- 239000012620 biological material Substances 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 150000003333 secondary alcohols Chemical class 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 6
- 239000004342 Benzoyl peroxide Substances 0.000 description 6
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 6
- 229940123457 Free radical scavenger Drugs 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 235000019400 benzoyl peroxide Nutrition 0.000 description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 6
- 238000003889 chemical engineering Methods 0.000 description 6
- MZRQZJOUYWKDNH-UHFFFAOYSA-N diphenylphosphoryl-(2,3,4-trimethylphenyl)methanone Chemical compound CC1=C(C)C(C)=CC=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 MZRQZJOUYWKDNH-UHFFFAOYSA-N 0.000 description 6
- 230000003301 hydrolyzing effect Effects 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 230000000269 nucleophilic effect Effects 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- JVCXFJJANZMOCM-UHFFFAOYSA-N phenyl(trimethylgermyl)methanone Chemical compound C[Ge](C)(C)C(=O)C1=CC=CC=C1 JVCXFJJANZMOCM-UHFFFAOYSA-N 0.000 description 6
- 239000002516 radical scavenger Substances 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- SRJQTHAZUNRMPR-UYQKXTDMSA-N spinosyn A Chemical compound O([C@H]1CCC[C@@H](OC(=O)C[C@H]2[C@@H]3C=C[C@@H]4C[C@H](C[C@H]4[C@@H]3C=C2C(=O)[C@@H]1C)O[C@H]1[C@@H]([C@H](OC)[C@@H](OC)[C@H](C)O1)OC)CC)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 SRJQTHAZUNRMPR-UYQKXTDMSA-N 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 description 6
- BKMMTJMQCTUHRP-UHFFFAOYSA-N 2-aminopropan-1-ol Chemical compound CC(N)CO BKMMTJMQCTUHRP-UHFFFAOYSA-N 0.000 description 5
- AMFGWXWBFGVCKG-UHFFFAOYSA-N Panavia opaque Chemical compound C1=CC(OCC(O)COC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OCC(O)COC(=O)C(C)=C)C=C1 AMFGWXWBFGVCKG-UHFFFAOYSA-N 0.000 description 5
- 238000007334 copolymerization reaction Methods 0.000 description 5
- 238000005886 esterification reaction Methods 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 150000003840 hydrochlorides Chemical class 0.000 description 5
- 238000010348 incorporation Methods 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 238000006386 neutralization reaction Methods 0.000 description 5
- 150000003138 primary alcohols Chemical class 0.000 description 5
- 230000001902 propagating effect Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 238000004566 IR spectroscopy Methods 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000005903 acid hydrolysis reaction Methods 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 238000005530 etching Methods 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 125000005842 heteroatom Chemical group 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000012417 linear regression Methods 0.000 description 4
- 239000012038 nucleophile Substances 0.000 description 4
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 238000000016 photochemical curing Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 230000009897 systematic effect Effects 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010162 Tukey test Methods 0.000 description 3
- CRFFPGKGPOBBHV-UHFFFAOYSA-N [benzoyl(diethyl)germyl]-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)[Ge](CC)(CC)C(=O)C1=CC=CC=C1 CRFFPGKGPOBBHV-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 125000003368 amide group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000011382 collagen catabolic process Effects 0.000 description 3
- 230000001010 compromised effect Effects 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 125000005520 diaryliodonium group Chemical group 0.000 description 3
- DCFSWWRUEHGVDF-UHFFFAOYSA-N dibenzoylgermanium Chemical class C=1C=CC=CC=1C(=O)[Ge]C(=O)C1=CC=CC=C1 DCFSWWRUEHGVDF-UHFFFAOYSA-N 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 150000002009 diols Chemical class 0.000 description 3
- OZLBDYMWFAHSOQ-UHFFFAOYSA-N diphenyliodanium Chemical compound C=1C=CC=CC=1[I+]C1=CC=CC=C1 OZLBDYMWFAHSOQ-UHFFFAOYSA-N 0.000 description 3
- RSJLWBUYLGJOBD-UHFFFAOYSA-M diphenyliodanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[I+]C1=CC=CC=C1 RSJLWBUYLGJOBD-UHFFFAOYSA-M 0.000 description 3
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- MGFYSGNNHQQTJW-UHFFFAOYSA-N iodonium Chemical class [IH2+] MGFYSGNNHQQTJW-UHFFFAOYSA-N 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 238000001543 one-way ANOVA Methods 0.000 description 3
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical class [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229910000077 silane Inorganic materials 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- IFLREYGFSNHWGE-UHFFFAOYSA-N tetracene Chemical compound C1=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C21 IFLREYGFSNHWGE-UHFFFAOYSA-N 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 238000004017 vitrification Methods 0.000 description 3
- SDEVOFCZKAPFID-UHFFFAOYSA-M (1-dodecylpyridin-1-ium-2-yl) 2-methylprop-2-enoate;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+]1=CC=CC=C1OC(=O)C(C)=C SDEVOFCZKAPFID-UHFFFAOYSA-M 0.000 description 2
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 2
- CFKBCVIYTWDYRP-UHFFFAOYSA-N 10-phosphonooxydecyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCCCCCOP(O)(O)=O CFKBCVIYTWDYRP-UHFFFAOYSA-N 0.000 description 2
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 2
- JZODKRWQWUWGCD-UHFFFAOYSA-N 2,5-di-tert-butylbenzene-1,4-diol Chemical compound CC(C)(C)C1=CC(O)=C(C(C)(C)C)C=C1O JZODKRWQWUWGCD-UHFFFAOYSA-N 0.000 description 2
- AFTBJQDQENGCPC-UHFFFAOYSA-N 2,5-ditert-butyl-4-methylphenol Chemical compound CC1=CC(C(C)(C)C)=C(O)C=C1C(C)(C)C AFTBJQDQENGCPC-UHFFFAOYSA-N 0.000 description 2
- VMZVBRIIHDRYGK-UHFFFAOYSA-N 2,6-ditert-butyl-4-[(dimethylamino)methyl]phenol Chemical compound CN(C)CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 VMZVBRIIHDRYGK-UHFFFAOYSA-N 0.000 description 2
- YGNYVPGLNHVYIO-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-3,5-bis(2-methylbutan-2-yl)phenol Chemical compound CCC(C)(C)C1=CC(C(C)(C)CC)=CC(O)=C1N1N=C2C=CC=CC2=N1 YGNYVPGLNHVYIO-UHFFFAOYSA-N 0.000 description 2
- IYAZLDLPUNDVAG-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 IYAZLDLPUNDVAG-UHFFFAOYSA-N 0.000 description 2
- VCYCUECVHJJFIQ-UHFFFAOYSA-N 2-[3-(benzotriazol-2-yl)-4-hydroxyphenyl]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 VCYCUECVHJJFIQ-UHFFFAOYSA-N 0.000 description 2
- XSHISXQEKIKSGC-UHFFFAOYSA-N 2-aminoethyl 2-methylprop-2-enoate;hydron;chloride Chemical compound Cl.CC(=C)C(=O)OCCN XSHISXQEKIKSGC-UHFFFAOYSA-N 0.000 description 2
- WFTYMNAJICQJIH-UHFFFAOYSA-N 2-aminopropyl 2-methylprop-2-enoate;hydrochloride Chemical compound Cl.CC(N)COC(=O)C(C)=C WFTYMNAJICQJIH-UHFFFAOYSA-N 0.000 description 2
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- WIYVVIUBKNTNKG-UHFFFAOYSA-N 6,7-dimethoxy-3,4-dihydronaphthalene-2-carboxylic acid Chemical compound C1CC(C(O)=O)=CC2=C1C=C(OC)C(OC)=C2 WIYVVIUBKNTNKG-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- KFABDCQUYUPNNX-UHFFFAOYSA-N C(C)(C)(C)C1=C(C(=CC(=C1)OCC)C(C)(C)C)O.C(C)(C)(C)C1=C(C(=CC(=C1)OC)C(C)(C)C)O Chemical compound C(C)(C)(C)C1=C(C(=CC(=C1)OCC)C(C)(C)C)O.C(C)(C)(C)C1=C(C(=CC(=C1)OC)C(C)(C)C)O KFABDCQUYUPNNX-UHFFFAOYSA-N 0.000 description 2
- DVAKYRFOCXFDRZ-UHFFFAOYSA-N CC(C[NH3+])OC(=O)C(=C)C.[Cl-] Chemical compound CC(C[NH3+])OC(=O)C(=C)C.[Cl-] DVAKYRFOCXFDRZ-UHFFFAOYSA-N 0.000 description 2
- 229920001651 Cyanoacrylate Polymers 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- 239000004146 Propane-1,2-diol Substances 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000002599 Smear Layer Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- KGQLBLGDIQNGSB-UHFFFAOYSA-N benzene-1,4-diol;methoxymethane Chemical compound COC.OC1=CC=C(O)C=C1 KGQLBLGDIQNGSB-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 238000001723 curing Methods 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 239000004851 dental resin Substances 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000003631 expected effect Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000004611 light stabiliser Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- ZZAOSLBVLOJDLM-UHFFFAOYSA-N n-(1-hydroxypropan-2-yl)-2-methylprop-2-enamide Chemical compound OCC(C)NC(=O)C(C)=C ZZAOSLBVLOJDLM-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 229950000688 phenothiazine Drugs 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000002186 photoactivation Effects 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 230000005588 protonation Effects 0.000 description 2
- 238000009790 rate-determining step (RDS) Methods 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 210000004357 third molar Anatomy 0.000 description 2
- ARCGXLSVLAOJQL-UHFFFAOYSA-N trimellitic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 238000004009 13C{1H}-NMR spectroscopy Methods 0.000 description 1
- QEPJZNUAPYIHOI-UHFFFAOYSA-N 2-(2-methylprop-2-enoylamino)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)NCCOC(=O)C(C)=C QEPJZNUAPYIHOI-UHFFFAOYSA-N 0.000 description 1
- RMCCONIRBZIDTH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 1,3-dioxo-2-benzofuran-5-carboxylate Chemical compound CC(=C)C(=O)OCCOC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 RMCCONIRBZIDTH-UHFFFAOYSA-N 0.000 description 1
- QCUCAQZMPVIYAJ-UHFFFAOYSA-N 2-(4-methyl-1h-indol-3-yl)ethanamine Chemical compound CC1=CC=CC2=C1C(CCN)=CN2 QCUCAQZMPVIYAJ-UHFFFAOYSA-N 0.000 description 1
- HVBCOZWSVRXIDO-UHFFFAOYSA-N 2-(benzotriazol-1-yl)-4-methylphenol Chemical compound CC1=CC=C(O)C(N2C3=CC=CC=C3N=N2)=C1 HVBCOZWSVRXIDO-UHFFFAOYSA-N 0.000 description 1
- MPFAYMDFVULHEW-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4-octylphenol Chemical compound CCCCCCCCC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MPFAYMDFVULHEW-UHFFFAOYSA-N 0.000 description 1
- GJKGAPPUXSSCFI-UHFFFAOYSA-N 2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone Chemical compound CC(C)(O)C(=O)C1=CC=C(OCCO)C=C1 GJKGAPPUXSSCFI-UHFFFAOYSA-N 0.000 description 1
- LYRWNAXKUQELGU-UHFFFAOYSA-N 2-Methacryloyloxyethyl phenyl phosphate Chemical compound CC(=C)C(=O)OCCOP(O)(=O)OC1=CC=CC=C1 LYRWNAXKUQELGU-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- JDKSTARXLKKYPS-UHFFFAOYSA-N 2-[10-(2-methylprop-2-enoyloxy)decyl]propanedioic acid Chemical compound CC(=C)C(=O)OCCCCCCCCCCC(C(O)=O)C(O)=O JDKSTARXLKKYPS-UHFFFAOYSA-N 0.000 description 1
- QLIBJPGWWSHWBF-UHFFFAOYSA-N 2-aminoethyl methacrylate Chemical compound CC(=C)C(=O)OCCN QLIBJPGWWSHWBF-UHFFFAOYSA-N 0.000 description 1
- CGWGNMXPEVGWGB-UHFFFAOYSA-N 2-hydroxy-1-[4-(2-hydroxyethyl)phenyl]-2-methylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=C(CCO)C=C1 CGWGNMXPEVGWGB-UHFFFAOYSA-N 0.000 description 1
- LTKVXDIHYHECND-UHFFFAOYSA-N 2-hydroxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCO.CC(=C)C(=O)OCCO LTKVXDIHYHECND-UHFFFAOYSA-N 0.000 description 1
- POLZHVHESHDZRD-UHFFFAOYSA-N 2-hydroxyethyl 2-methylprop-2-enoate;phosphoric acid Chemical compound OP(O)(O)=O.CC(=C)C(=O)OCCO POLZHVHESHDZRD-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- ZDMZLTIFXMREFI-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate;phosphoric acid Chemical compound OP(O)(O)=O.OCCOC(=O)C=C ZDMZLTIFXMREFI-UHFFFAOYSA-N 0.000 description 1
- SEILKFZTLVMHRR-UHFFFAOYSA-N 2-phosphonooxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOP(O)(O)=O SEILKFZTLVMHRR-UHFFFAOYSA-N 0.000 description 1
- IQAGXMNEUYBTLG-UHFFFAOYSA-N 5-hydroxy-2-methylpent-2-enamide Chemical compound NC(=O)C(C)=CCCO IQAGXMNEUYBTLG-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- OINCOJPECXROJF-UHFFFAOYSA-N CC(=C)C(N)=O.CC(=C)C(=O)NCCO Chemical group CC(=C)C(N)=O.CC(=C)C(=O)NCCO OINCOJPECXROJF-UHFFFAOYSA-N 0.000 description 1
- SUOUXXKZVDHWJJ-UHFFFAOYSA-N CCC(COC(=O)C(C)=C)NC(=O)C(C)=C Chemical compound CCC(COC(=O)C(C)=C)NC(=O)C(C)=C SUOUXXKZVDHWJJ-UHFFFAOYSA-N 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- OWYWGLHRNBIFJP-UHFFFAOYSA-N Ipazine Chemical compound CCN(CC)C1=NC(Cl)=NC(NC(C)C)=N1 OWYWGLHRNBIFJP-UHFFFAOYSA-N 0.000 description 1
- 238000012313 Kruskal-Wallis test Methods 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000004830 Super Glue Substances 0.000 description 1
- AVUYXHYHTTVPRX-UHFFFAOYSA-N Tris(2-methyl-1-aziridinyl)phosphine oxide Chemical compound CC1CN1P(=O)(N1C(C1)C)N1C(C)C1 AVUYXHYHTTVPRX-UHFFFAOYSA-N 0.000 description 1
- KPQPULNPJZWBRB-UHFFFAOYSA-N [2-methyl-1-(2-methylprop-2-enoylamino)propan-2-yl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)NCC(C)(C)OC(=O)C(C)=C KPQPULNPJZWBRB-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000010945 base-catalyzed hydrolysis reactiony Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- PODOEQVNFJSWIK-UHFFFAOYSA-N diphenylphosphoryl-(2,4,6-trimethoxyphenyl)methanone Chemical compound COC1=CC(OC)=CC(OC)=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 PODOEQVNFJSWIK-UHFFFAOYSA-N 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 239000013628 high molecular weight specie Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- JUYQFRXNMVWASF-UHFFFAOYSA-M lithium;phenyl-(2,4,6-trimethylbenzoyl)phosphinate Chemical compound [Li+].CC1=CC(C)=CC(C)=C1C(=O)P([O-])(=O)C1=CC=CC=C1 JUYQFRXNMVWASF-UHFFFAOYSA-M 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- OKPYIWASQZGASP-UHFFFAOYSA-N n-(2-hydroxypropyl)-2-methylprop-2-enamide Chemical compound CC(O)CNC(=O)C(C)=C OKPYIWASQZGASP-UHFFFAOYSA-N 0.000 description 1
- 238000001422 normality test Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical group CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- KLGAMXCNLDAFGI-UHFFFAOYSA-N phosphoric acid prop-2-enoic acid Chemical compound OC(=O)C=C.OC(=O)C=C.OC(=O)C=C.OC(=O)C=C.OC(=O)C=C.OP(O)(O)=O KLGAMXCNLDAFGI-UHFFFAOYSA-N 0.000 description 1
- 238000011417 postcuring Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- DDFYFBUWEBINLX-UHFFFAOYSA-M tetramethylammonium bromide Chemical compound [Br-].C[N+](C)(C)C DDFYFBUWEBINLX-UHFFFAOYSA-M 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- ORGHESHFQPYLAO-UHFFFAOYSA-N vinyl radical Chemical compound C=[CH] ORGHESHFQPYLAO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
- A61K6/62—Photochemical radical initiators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/30—Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
Definitions
- the present invention concerns amine ⁇ terminated and methacrylate/methacrylamide monomers for dental adhesive applications.
- STATEMENT OF GOVERNMENT SUPPORT This invention was made with government support under 1U01 ⁇ DE023756, 1R01 ⁇ DE026113, K02 ⁇ DE025280; R01 ⁇ DE028757; and R35 ⁇ DE029083 awarded by NIH ⁇ NIDCR. The government has certain rights in the invention. BACKGROUND OF THE INVENTION Dental adhesive interfaces with reduced susceptibility to degradation could lead to dental restorations with extended clinical lifetimes.
- Degradation is the result of two factors: (1) collagen degradation by endogenous proteases [ Mazzoni et al., Endodontic Topics. 2009;21:19 ⁇ 40], [ Tjäderhane et al., Dent Mater. 2013;29:116 ⁇ 35], and (2) polymer hydrolysis.
- the hydrolysis of dental adhesives – specifically the ester functionality within the polymer – is catalyzed by acid (low pH) as well as bacterial/salivary esterases [Santerre et al., Critical Reviews in Oral Biology & Medicine. 2001;12:136 ⁇ 51], [Tay et al., Journal of Dentistry.
- This sterically derived hydrolytic stability factor is approximately the same for both ester and amide hydrolysis.
- additional hydrolytic stability could be imparted to the material both at the ester and the amide groups by the synthetic inclusion of chemically inert methyl groups.
- One important point to consider is that the same factors that make amide bonds more stable than acrylate bonds also affect polymerization rate (Scheme 2 in supplemental materials). Neat methacrylamides tend to have slower polymerization kinetics compared to methacrylates [Barcelos et al., Dental Materials.
- methacrylamide ⁇ methacrylate co ⁇ polymerizations can lead to significant gains in dentin bond strength stability, while only marginally affecting polymerization rate [Fugolin et al., Dental Materials. 2019;35:686 ⁇ 96]. It is currently unclear how methylation as mentioned above affects the polymerization kinetics and the final material properties and there remains a need for more stable dental adhesives. SUMMARY OF THE INVENTION Ester ⁇ free monomers have been suggested as more stable alternatives for dental adhesives. Specifically, alpha and beta ⁇ carbon substitutions have been shown to slow down degradation of polymeric networks.
- the new class of monomers described here comprises systematic variations of mono and hybrid difunctional methacrylate/methacrylamides with alkyl chains being used as substitutions on the alpha or beta positions in relation to the polymerizable group.
- Monofunctional monomers are shown in Figure 1 and hybrid monomers are shown in Figure 2. All monomers have been synthesized, and selected monomers have been evaluated in terms of kinetics of polymerization and long ⁇ term microtensile bond strength as part of the formulation of dental adhesives.
- One embodiment herein provides a dental adhesive composition
- a dental adhesive composition comprising one or more of: a) a hydroxyl ⁇ terminated methacrylamide compound selected from the group of: b) a hydroxyl ⁇ terminated methacrylate compound selected from the group of: ; or c) an amino ⁇ terminated methacrylate compound selected from the group of: ; or d) a di ⁇ functional methacrylamide/methacrylate compound selected from the group of: .
- FIGURE 1 presents a bar graph of the percentage degree of conversion for three tested monomers.
- FIGURE 2 presents a line graph representing kinetics of polymerization curves (average of three curves) for six tested monomers.
- FIGURE 3 presents a line graph representing kinetics of polymerization results at 50 °C for HEMA, HEMAM and 2 ⁇ methyl HEMAM.
- FIGURE 4 presents a bar graph representing the shear storage modulus values determined for the hybrids HEMAM Hy and 2dMM Hy.
- FIGURE 5 presents a table of half ⁇ lives for monomers in acidic aqueous conditions at 37°C (data were fit to an exponential decay model).
- FIGURE 6 depicts steric interactions of ⁇ carbon alkyl substituents have been shown to cause 2° and 3° amides to twist about the C ⁇ N bond.
- FIGURE 7 presents bar graphs comparing water sorption and solubility determined for tested monomers.
- FIGURE 8 presents images of comparative cracking in tested polymers.
- FIGURE 9 presents line graphs representing the kinetics curves profiles of HEMA, HEMAM and HEMAM Hy.
- FIGURE 10 presents a table of %DC at inflection of a deceleration curve for HEMA, HEMAM, and HEMAN Hy.
- compositions comprising a compound selected from groups a) ⁇ d) above and one or more comonomers selected from the group of bisphenol A diglycidyl ether dimethacrylate (BisGMA), triethylene glycol dimethacrylate (TEGDMA), urethane dimethacrylate (UDMA), ethylene glycol dimethylacrylate (EGDMA), ethane ⁇ 1,2 ⁇ diyl bis(2 ⁇ methylacrylate) (PEGDMA), ethoxylated bisphenol A dimethacrylate (EBPADMA), ethylene glycoldi(meth)acrylate, hexanediol di(meth)acrylate, tripropylene glycol di(meth)acrylate, butanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate
- the co ⁇ monomer or co ⁇ monomers selected from this group comprises from about 55% to 65% of the composition, by weight. Still other embodiments provide such compositions comprising at least one monomer and one co ⁇ monomer, as described herein, and further comprising a polymerization initiator, such as one selected from the group of camphorquinone (CQ); trimethylbenzoyl ⁇ diphenyl ⁇ phosphine oxide (TPO); Ethyl ⁇ 4 ⁇ dimethylamino benzoate (EDMAB); 2,2 ⁇ Dimethoxy ⁇ 2 ⁇ phenylacetophenone (DMPA); Bisacylphosphine oxide (BAPO); 1 ⁇ Phenyl ⁇ 1,2 ⁇ propanedione (PPD); phosphine oxide compounds, including naphthacene (APO), 9 ⁇ anthracene (APO), and bisacylphosphine oxide (BAPO); 1 ⁇ phenyl ⁇ 1,2 ⁇ propanedione (PPD); thioxanthone (CQ); tri
- the polymerization initiator is a combination of initiators, such as those selected from the group of camphorquinone/ethyl ⁇ 4 ⁇ (dimethylamino)benzoate (EDMAB), camphorquinone/2 ⁇ (dimethylamino)ethyl methacrylate (DMAEMA)), DMPA/DPI ⁇ PF6, CQ/PPD, CQ/DMAEMA, CQ/EDMAB, CQ/DMAEMA/PDIHP, or CQ/EDMAB/DPIHP.
- the polymerization initiator one or both of the group DMPA and DPI ⁇ PF.
- the polymerization initiator comprises from about 0.05% to about 0.6% of the composition, by weight.
- the composition also comprises a chemical inhibitor (also referred to as a stabilizer or free radical scavengers ), such as one selected from the group of butylated hydroxytoluene (BHT), hydroquinone, 2,5 ⁇ di ⁇ tert ⁇ butyl hydroquinone, monomethyl ether hydroquinone (MEHQ), and 2,5 ⁇ di ⁇ tertiary butyl ⁇ 4 ⁇ methylphenol, 3,5 ⁇ di ⁇ tert ⁇ butyl ⁇ 4 ⁇ hydroxyanisole (2,6 ⁇ di ⁇ tert ⁇ butyl ⁇ 4 ⁇ ethoxyphenol), 2,6 ⁇ di ⁇ tert ⁇ butyl ⁇ 4 ⁇ (dimethylamino)methylphenol or 2 ⁇ (2′ ⁇ hydroxy ⁇ 5′ ⁇ methylphenyl) ⁇ 2H ⁇ benzotriazole, 2 ⁇ (2′ ⁇ hydroxy ⁇ 5′ ⁇ t ⁇ octylphenyl) ⁇ 2H ⁇ benzotriazole, 2 ⁇ (2′ ⁇ hydroxy ⁇ 4′,6′ ⁇ di ⁇ tert ⁇ pent
- BHT
- compositions may also comprise an ultraviolet light (UV) absorber, such as 2 ⁇ hydroxy ⁇ 4 ⁇ methoxybenzophenone (UV ⁇ 9), 2 ⁇ (2 ⁇ Hydroxy ⁇ 5 ⁇ octylphenyl) ⁇ benzotriazole (UV ⁇ 5411), salicylic acid phenyl ester, 3 ⁇ (2′ ⁇ hydroxy ⁇ 5′ ⁇ methylphenyl)benzotriazole, and 2 ⁇ (2' ⁇ hydroxy ⁇ 5' ⁇ methylphenyl) ⁇ benzotriazole.
- UV absorber may be present in the composition at from about 0.001% to about 0.5%, by weight.
- the chemical inhibitor is incorporated into the composition at a concentration of from about 0.01% to about 0.5%, by weight.
- the chemical inhibitor is present in the composition at from about 0.05% to about 0.3%, by weight. In still other embodiments, the chemical inhibitor is present in the composition at from about 0.05% to about 0.2%, by weight. In additional embodiments, the chemical inhibitor is present in the composition at from about 0.05% to about 0.15%, by weight. It is understood that the compositions herein may include further elements, such as a fluorescent agent, a fluoride releasing agent, a radiopaque agent, a flavoring agent, and an antimicrobial agent. Purpose/aim: Ester ⁇ free monomers have been suggested as more stable alternatives for dental adhesives. Specifically, alpha and beta ⁇ carbon substitutions have been shown to slow down degradation of polymeric networks.
- the aim of this study was to evaluate kinetics of polymerization and long ⁇ term microtensile bond strength of dental adhesives formulated with novel secondary methacrylamides.
- Materials and methods Secondary methacrylamides with different carbon substitutions (alpha ⁇ 2MM, beta ⁇ 3MM and no substitution ⁇ HEMAM) were copolymerized with UDMA at 40/60 mass ratio. 0.2 wt% DMPA and 0.4 wt% DPI ⁇ PF6 were used as photoinitiators. Polymerization kinetics was followed with near ⁇ IR in real ⁇ time (6165 ⁇ 6135 cm ⁇ 1 ) for 300s at 800 mW/cm 2 (320–500 nm).
- the dental adhesive compositions herein may include one or more photoinitiator agents.
- initiator or “polymerization initiator” herein refers to thermal initiating, redox ⁇ initiating, and/or photoinitiating compounds capable of inducing polymerization throughout a significant depth of composite material, such as camphorquinone (CQ); trimethylbenzoyl ⁇ diphenyl ⁇ phosphine oxide (TPO); Ethyl ⁇ 4 ⁇ dimethylamino benzoate (EDMAB); 2,2 ⁇ Dimethoxy ⁇ 2 ⁇ phenylacetophenone (DMPA); Bisacylphosphine oxide (BAPO); 1 ⁇ Phenyl ⁇ 1,2 ⁇ propanedione (PPD); phosphine oxide compounds, including naphthacene (APO), 9 ⁇ anthracene (APO), and bisacylphosphine oxide (BAPO); 1 ⁇ phenyl ⁇ 1,2 ⁇ propanedione (PPD); thioxanthone (TX) and its derivatives; dibenzoyl germanium derivatives, such as be
- one initiator material may be used or 2 or more may be used, such as the combination of camphorquinone with a co ⁇ initiator, such as a tertiary amine initiator (such as ethyl ⁇ 4 ⁇ (dimethylamino) benzoate (EDMAB) and/or 2 ⁇ (dimethylamino)ethyl methacrylate (DMAEMA)), or a combination of DMPA/DPI ⁇ PF6, CQ/PPD, CQ/DMAEMA, CQ/EDMAB, CQ/DMAEMA/PDIHP, or CQ/EDMAB/DPIHP.
- a co ⁇ initiator such as a tertiary amine initiator (such as ethyl ⁇ 4 ⁇ (dimethylamino) benzoate (EDMAB) and/or 2 ⁇ (dimethylamino)ethyl methacrylate (DMAEMA)
- EDMAB tertiary amine initiator
- photoinitiators for use with the present compositions include monoacylphoshine oxide (MAPO, available from Lucirin TPO, BASF), bisacylphosphine oxide (BAPO, Irgacure 819, Ciba Geigy), phenylpropanedione (PPD, Aldrich), and camphorquinone (CQ, Aldrich).
- MAPO monoacylphoshine oxide
- BAPO bisacylphosphine oxide
- PPD phenylpropanedione
- CQ camphorquinone
- Tested Co ⁇ monomers The commercially ⁇ available monomers used in this study were purchased from Sigma Aldrich (Milwaukee, WI, USA) at 95% or greater purity, and used as received: 2 ⁇ hydroxyethyl methacrylate – HEMA, 2 ⁇ hydroxyethyl methacrylamide – HEMAM, 2 ⁇ hydroxy ⁇ 2 ⁇ methylethyl methacrylamide – 2 ⁇ methyl HEMAM. Hydroxypropyl methacrylate was obtained as a mixture of isomers consisting of the ⁇ substituted 2 ⁇ hydroxy ⁇ 1 ⁇ methylethyl methacrylate – 1 ⁇ methyl HEMA, and ⁇ substituted 2 ⁇ hydroxy ⁇ 2 ⁇ methylethyl methacrylamide – 2 ⁇ methyl HEMA.
- composition of the mixture was determined by 1 H NMR spectroscopy to be 72% 2 ⁇ methyl HEMA and 28% 1 ⁇ methyl HEMA, consistent with the distributer's analysis.
- the hydroxypropyl methacrylate isomeric mixture was used as received due to facile isomerization equilibrium (discussed later).
- 2 ⁇ hydroxy ⁇ 1 ⁇ methylethyl methacrylamide – 1 ⁇ methyl HEMAM was synthesized de novo (see supplementary information). The structures of all monomers used in this study are shown below.
- the monomers above may be copolymerized with monomers, particularly dental resin monomers (UDMA, BisGMA, etc.), in dental adhesive compositions.
- UDMA dental resin monomers
- UDMA dental resin monomers
- BisGMA BisGMA
- AEMA aminoethyl methacrylate
- Spectra were collected for 330 s, with 2 scans per spectrum at 4 cm ⁇ 1 resolution. The light was kept on for the duration of the experiment to provide isothermal conditions, and avoid overestimation of conversion due to potential IR pathlength reduction (had the light been turned off during the experiment, causing shrinkage of the specimen). The followed peaks were 6165 and 6135 cm ⁇ 1 for methacrylates and methacrylamides, respectively.
- the maximum rate of polymerization (RP MAX ) was calculated as the first derivative of the degree of conversion vs. time curve, and the final degree of conversion (Final DC) was based on the change in area of the vinyl overtone peaks.
- the degree of conversion at the maximum rate of polymerization (DC at RP MAX ) was used as a proxy for the onset of vitrification. Since the ⁇ substituted secondary methacrylamide 2 ⁇ methyl AEMA was not soluble in the organic matrix at room temperature, the mixture was heated on a hot plate to 50 °C and the kinetics tested immediately at the same conditions described above. For an appropriate comparison, the methacrylamide and methacrylate controls – HEMAM and HEMA, were also tested at 50 ⁇ C, as controls. Formulations that did not cure or cured very slowly were not subjected to dentin microtensile bond strength or monomer hydrolysis kinetics.
- Dentin microtensile bond strength Sound human dentin from extracted third molars was used as the substrate for microtensile bond strength ( ⁇ TBS) (project approved by Oregon Health & Science University – IRB #00012056). Ethanol was added at 40 vol% to the selected monomer compositions. Briefly, enamel was removed to expose a flat surface of mid ⁇ coronal dentin. A smear layer was created on this surface using 600 grit sandpaper for 30 s followed by etching with 35% phosphoric acid (3M ESPE, St. Paul, MN, USA) for 15 s and rinsing for 10 s.
- 3M ESPE 35% phosphoric acid
- a capillary tube was filled with a 50 mM solution of tetramethylammonium bromide dissolved in D 2 O and flame sealed. The capillary tube was placed at the bottom of the NMR tube to allow the locking of the magnet on the instrument onto the deuterium of the inner ⁇ tube with the ammonium acting as an internal standard.
- 1 H NMR spectra were obtained using a water suppression by excitation sculpting experiment [Mobarhan et al., Analytical and Bioanalytical Chemistry. 2017;409:5043 ⁇ 55]. After the initial reading, the NMR tubes were flame sealed and incubated at 37 °C.
- the methacrylamides, HEMAM and 1 ⁇ methyl HEMAM presented intermediate RP MAX values: 13.0 and 13.3%.s ⁇ 1 , respectively.
- the DC at RP MAX ranged between 35.1% and 16.7%.
- OH ⁇ terminated methacrylates showed the highest values (35.1% and 31.6% for HEMA and HEMA ⁇ , ⁇ CH 3 mixture, respectively), followed by the methacrylamides (22.2% and 24.3% for HEMAM and 1 ⁇ methyl HEMAM, respectively).
- the NH 2 ⁇ terminated 1 ⁇ methyl and 2 ⁇ methyl AEMA presented the lowest values: 15.7% and 16.7%, respectively.
- the unsubstituted methacrylamide, HEMAM experienced the least degradation with 89.1 ⁇ 0.01% of the monomer remaining intact after 17 days of incubation.
- the substituted methacrylamides, 2 ⁇ methyl HEMAM and 1 ⁇ methyl HEMAM both exhibited more degradation than HEMAM, with 83.5 ⁇ 0.5% and 65.4 ⁇ 1.3% intact monomer remaining.
- the two methacrylate monomers exhibited similar degradation amounts, HEMA with 25.2 ⁇ 0.1% intact monomer after 19 days incubation and the ⁇ , ⁇ CH 3 HEMA mixture with 31.9 ⁇ 0.4% intact monomer after 17 days incubation.
- HEMA methylated derivative is only available as a mixture of isomers. This isomerization is very likely occurring via a low ⁇ energy transesterification mechanism [33].
- the ⁇ substituted 1 ⁇ methyl HEMA is particularly susceptible to this isomerization.
- the terminal hydroxyl group participates in a transesterification resulting in a dimethacrylate and propane ⁇ 1,2 ⁇ diol (Scheme 3 in supplemental materials).
- Another transesterification occurs resulting in two monomethacrylates.
- the secondary alcohol of the diol would need to participate in the transesterification while the more nucleophilic primary alcohol results in 2 ⁇ methyl HEMA.
- the terminal hydroxyl group participates in a transesterification resulting in a dimethacrylate and propane ⁇ 1,2 ⁇ diol (Scheme 3 in supplemental materials). Another transesterification occurs resulting in two monomethacrylates. In order to return to the original monomethacrylate, the secondary alcohol of the diol would need to participate in the transesterification while the more nucleophilic primary alcohol results in 2 ⁇ methyl HEMA. This difference in nucleophilicity explains why an eventual equilibrium of a 3:1 ratio of 2 ⁇ methyl HEMA to 1 ⁇ methyl HEMA is reached in commercial HEMA ⁇ , ⁇ CH 3 . This transesterification will not result in an isomerization in unsubstituted monomers, like HEMA, though the dynamic behavior is likely still occurring.
- the OH ⁇ terminated methacrylate HEMA (control) presented the highest values of DC at RP MAX and final DC when polymerized at 50 °C, with HEMAM and 2 ⁇ methyl HEMAM being similar to each other. This was expected due to the differences in molecular weight, viscosity and reactivity among the compounds, as discussed above.
- the similarity of RP MAX among HEMA and the secondary methacrylamides was also observed for the polymerization kinetics evaluated at room temperature in this study and previously reported [Fugolin et al., Dental Materials. 2019;35:686 ⁇ 96].
- HEMA has low molecular weight and viscosity (130 g/mol and 0.007 Pa.s), which increases the overall mobility within the comonomer system. This allows for a rapid increase in the rates of propagation and termination at the beginning of the polymerization reaction, until the formation of high molecular weight species severely hamper diffusion [Odian G. Principles of polymerization: John Wiley & Sons; 2004]. Despite methacrylates having higher reactivity than methacrylamides, the observed RP MAX values were similar. This observation reinforces that the methacrylamide ⁇ methacrylate blend ratio used in this study provides good properties without a significant loss of polymerization reactivity.
- the low ⁇ TBS of the HEMA ⁇ , ⁇ CH 3 mix stands in contrast to the excellent polymerization kinetics observed. It is possible that the high polymerization rates and side ⁇ group substitutions at the ⁇ and ⁇ carbons might have resulted in a poorly packed polymer network with compromised mechanical properties [Pfeifer et al., European Polymer Journal. 2011;47:162 ⁇ 70].
- the ⁇ substituted 2 ⁇ methyl HEMAM showed a statistically equivalent ⁇ TBS to the other secondary methacrylamides (HEMAM and 1 ⁇ methyl HEMAM), though lower than Single Bond.
- HEMAM and 1 ⁇ methyl HEMAM maintained the highest bond strengths
- 2 ⁇ methyl HEMAM showed intermediate results
- the experimental methacrylates HEMA and HEMA ⁇ , ⁇ CH 3 mix the lowest bonds, which once again highlights the degradation resistance of the methacrylamides.
- the reduction in ⁇ TBS over time ranged between 37.5% for the methacrylate control, HEMA, and 5.7% for the ⁇ substituted secondary methacrylamide, 1 ⁇ methyl HEMAM, which can be explained by the increased resistance to hydrolysis of the methacrylamides compared to their methacrylate counterparts.
- HEMA and HEMA ⁇ , ⁇ CH 3 had a half ⁇ life of 9.52 days (linear regression), while the worst performing methacrylamide, 1 ⁇ methyl HEMAM, had a half ⁇ life of 27.7 days.
- the HEMA ⁇ , ⁇ CH 3 mixture of isomers was mostly composed of the ⁇ substituted 2 ⁇ methyl HEMA (3:1), but this appeared to have no benefit or detriment to the stability to acid ⁇ catalyzed hydrolysis compared to HEMA.
- the hydrolysis results confirmed the expected increased resistance to hydrolysis, as all methacrylate monomers showed significantly more degradation in acidic aqueous conditions than the methacrylamide monomers.
- the HEMA ⁇ , ⁇ CH 3 mixture of isomers was mostly composed of the ⁇ substituted 2 ⁇ methyl HEMA (3:1), but this appeared to have no benefit or detriment to the stability to acid ⁇ catalyzed hydrolysis compared to HEMA. Interestingly, the addition of a ⁇ or ⁇ CH 3 groups had a detrimental effect (i.e., increased hydrolysis rate).
- the ⁇ , ⁇ CH 3 methacrylamides (1 ⁇ methyl and 2 ⁇ methyl HEMAM) showed higher degradation rates (half ⁇ lives of 68.8 and 27.7 days, respectively) compared to unsubstituted HEMAM (half ⁇ life of 101 days).
- Scheme 1 represents steric influence of side ⁇ chain functionality on the relative rates of base catalyzed ester hydrolysis and amide hydrolysis (Charton 1978). Note that ⁇ Me substituents have a maximum effect of ⁇ 1.5 ⁇ 1.8 times slower hydrolysis.
- Scheme 2 below provides a) General reaction scheme for amide and ester polymerization and subsequent hydrolysis. b) Resonance structures for the radical polymerization intermediate showing propagating and non ⁇ propagating resonance differences between esters and amides.
- X O minor resonance form
- X NH major resonance form
- Scheme 3 depicts 1 ⁇ methyl HEMA as an example of isomerization through transesterification of substituted hydroxyl ⁇ terminated methacrylates towards thermodynamic equilibrium resulting in a mixture of isomers.
- Figure 6 provides names and abbreviations of the evaluated monomers along with the associated transesterification and degradation products.
- Synthesis and characterization of 1 ⁇ methyl HEMAM N ⁇ (1 ⁇ hydroxypropan ⁇ 2 ⁇ yl)methacrylamide (1 ⁇ methyl HEMAM) Freshly distilled methacryloyl chloride (60.0 mmol, 1 equiv.) in anhydrous DCM (20 mL) was added dropwise to a stirred solution of 2 ⁇ aminopropanol (63.0 mmol, 1.05 equiv.), trimethylamine (60.0 mmol, 1 equiv.) and 5 mg of 4 ⁇ methoxyphenol in anhydrous DCM (30 mL) at ⁇ 5 °C.
- the crude product was purified using a Buchi Reveleris X2 flash chromatography system (mobile phase A was hexanes and mobile phase B (MPB) was EtOAc, with a gradient program of 11% MPB for 1 min, 11% MPB to 47% MPB over 14.3 min and hold at 47% for 7.2 min). The fractions were collected and concentrated under reduced pressure, yielding the final product as an off ⁇ white solid (25.9 mmol, 43.2% yield).
- Methacryloyl chloride (54.1 mmol, 1.2 equiv) was added and stirred for 2 hours. A sweep of N 2 gas was bubbled into a saturated sodium bicarbonate aqueous solution to trap the resulting HCl gas. After cooling to 40 °C, 12 mL of THF was added and the resulting solution was added dropwise to 100 mL of diethyl ether, precipitating a white solid (21.8 mmol, 48.3% yield).
- the alcohol of 2 ⁇ methyl HEMAM is much less nucleophilic as a secondary alcohol and would have a much slower re ⁇ esterification reaction back to 1 ⁇ methyl AEMA, resulting in an equilibrium with mostly transesterification product and very little 1 ⁇ methyl AEMA.
- the unsubstituted version resulted in very little of the transesterification product HEMAM. This could possibly suggest that transesterification occurs through both an intermolecular mechanism and an intramolecular mechanism.
- the addition of steric bulk in the form of methyl substituents would be expected to favor intramolecular transesterification due to the Thorpe ⁇ Ingold effect and could explain why there is more transesterification products in the 1 ⁇ methyl and 2 ⁇ methyl AEMA samples.
- HEMAM secondary methacrylamide N ⁇ hydroxyethyl methacrylamide
- Triethyleneglycol dimethacrylate (TEGDMA) was tested as difunctional methacrylate control to provide a comparison with the difunctional methacrylamide ⁇ methacrylate hybrid monomers.
- the partition coefficient (log P) for each monomer was calculated using the software package Chem Draw Ultra 14.1 (Perkin Elmer, San Jose, CA, USA). Tested formulations and photocuring conditions The monomers shown in Figure 1 were mixed at 40 mass% with bisphenol A ⁇ glycidyl methacrylate (bisGMA).
- Butylated hydroxytoluene (BHT) was added at 0.1 mass% to each formulation as a free ⁇ radical inhibitor.
- the degree of conversion at the maximum rate of polymerization was used to estimate the time point in conversion at which diffusional limitations lead to deceleration.
- WS and SL were calculated in ⁇ g/mm 3 according the following equations, where V is the volume of the disc in mm 3 :
- the dentin surface was etched for 15 s with 37% phosphoric acid (3M ESPE), rinsed and dried with the aid of gentle air stream for about 10 s.
- Two layers of the adhesive were applied and, after solvent evaporation, the second layer was photocured for 60 s at 630 mW/cm 2 by the mercury arc lamp.
- Restorative procedures consisted of a block of Filtek Supreme (shade A2 ⁇ 3M ESPE) built in 2 increments of 2 mm each, photoactived with the light guide directly over the surface for 20 s at 1200 mW/cm 2 with an Elipar TM DeepCure ⁇ S LED (3M ESPE).
- the monofunctional HEMA and HEMAM showed the highest values (89.0 and 83.2%, respectively) and the hybrid versions HEMAM Hy, 2EM Hy and 2dMM Hy the lowest (63.5, 63.3, and 59.4%, respectively).
- the alpha ⁇ substituted methacrylamides 2EM and 2dMM showed lower values than the monofunctional methacrylate control HEMA (73.6, 76.7 and 89.0%, respectively).
- the WS values ranged between 33.4 ⁇ 3.2 and 183.0 ⁇ 5.7 ⁇ g/mm 3 with the highest value being for the methacrylamide HEMAM, followed by 2EM, HEMA and 2dMM (101.3 ⁇ 1.5, 93.9 ⁇ 4.8, and 79.1 ⁇ 0.9 ⁇ g/mm 3 , respectively).
- TEGDMA and the hybrids were similar (35.5 ⁇ 1.8, 38.7 ⁇ 1.8, 44.0 ⁇ 0.8, and 33.4 ⁇ 3.2 ⁇ g/mm 3 , respectively).
- the results ranged between ⁇ 12.7 ⁇ 1.6 and 6.4 ⁇ 2.2 ⁇ g/mm 3 for HEMA and 2EM/2dMM, respectively.
- the hybrids HEMAM Hy, 2EM Hy and 2dMM Hy were statistically similar to TEGDMA ( ⁇ 1.6 ⁇ 0.0, 0.0 ⁇ 0.0, ⁇ 0.5 ⁇ 2.4, and ⁇ 4.2 ⁇ 6.0 ⁇ g/mm 3 , respectively).
- the shear storage modulus, G’ values ranged between 160.7 ⁇ 8.0 and 115.7 ⁇ 7.0 MPa for the hybrids HEMAM Hy and 2dMM Hy, respectively ( Figure 4).
- the groups were statistically similar and significant difference was only observed between HEMAM Hy versus TEGDMA, 2EM and 2dMM Hy. Dentin ⁇ TBS results are shown in Figure 5.
- HEMAM Hy all hybrid versions showed reactivity (RP MAX ) similar to the methacrylate controls (TEGDMA and HEMA).
- RP MAX methacrylate controls
- HEMAM was expected to present the highest reactivity due to the absence of bulky substituents. The absence of substituents, in theory, would facilitate the access of the amine radicals to the vinyl groups. Albeit not statistically significant, the opposite was actually observed: the non ⁇ substituted HEMAM showed 45% lower RP MAX than the alpha ⁇ substituted versions. Steric interactions of substituents near amide bonds have been shown to cause slight rotation about the amide C ⁇ N bond [Wang et al., Journal of the American Chemical Society.
- the resulting “distorted” amides have less pi ⁇ orbital overlap resulting in lengthened C ⁇ N bonds and less electron donation of the lone pair into the conjugated system of the amide [16].
- the reduced electron donation and resulting reduction in radical stabilization is being used as a possible explanation for the reduced reactivity and rate of polymerization between non ⁇ substituted monomers and monomers with one or more ⁇ carbon substituents.
- One additional explanation is based on the electron ⁇ donating nature of the alkyl chains, which may have created a partial negative charge on the alpha ⁇ carbon in 2EM and 2dMM [Bruice PY. Essential organic chemistry2016].
- the methacrylamides are markedly less reactive than the methacrylates due to the strong resonance stabilization of the vinyl group provided by the nitrogen atom [Miyake et al., Macromolecules. 2009;42:1462 ⁇ 71].
- the amide functionality is more stabilized than the ester due to the fact that the nitrogen atom is less electronegative than the oxygen and, consequently, is a better donor of nonbonding electrons [Kucharski et al., Journal of Applied Polymer Science. 1997;64:1259 ⁇ 65]. Therefore, it can be postulated that the more reactive methacrylate reacted first, further decreasing the reactivity of the already stable methacrylamide functionality.
- the decrease in viscosity promoted by the incorporation of HEMA, HEMAM and HEMAM Hy into the formulations may increase the mobility of the system, which may have caused the polymerization of the more reactive bisGMA to take place more or less independently, at a faster rate and with earlier vitrification compared with the other co ⁇ monomers [[Pfeifer et al., Journal of Polymer Science Part A: Polymer Chemistry. 2014;52:1796 ⁇ 806].
- the polymerization of the diluent ⁇ rich phase is hypothesized to have taken place at a slower rate, with delayed gelation and vitrification.
- HEMAM non ⁇ substituted HEMAM showed statistically higher final degree of conversion than the alpha ⁇ substituted versions 2dMM and 2EM.
- the increase in final double bond conversion showed by HEMAM may be associated with the relative lower viscosity of this compound, which likely played a role in preserving sufficient mobility in the system up to much higher levels in conversion [Odian G. Principles of polymerization: John Wiley & Sons; 2004].
- Methacrylamides have hydrogen ⁇ bond acceptor (O ⁇ H dipole) and hydrogen ⁇ bond donor (N ⁇ H dipole) capabilities, which favors their interaction with water [DeRuiter et al., Principles of Drug Action. 2005;1:1 ⁇ 16].
- methacrylate functionality on the secondary methacrylamides was to reduce the latter’s hydrophilicity.
- the methacrylate ⁇ methacrylamide hybrids (HEMAM Hy, 2EM Hy, and 2dMM Hy) showed dramatic reduction in water sorption in comparison to their methacrylamide versions (HEMAM, 2EM, and 2dMM) ( Figure 7), with methacrylate hybrids showing 3 to 6 ⁇ fold greater log P values. This means they are a lot more hydrophobic than the methacrylamide analogs.
- HEMAM Hy showed the highest values and 2dMM Hy and TEGDMA the lowest ones, which indicates that the molecular packing and the intermolecular interactions are playing key roles. It is known for co ⁇ polymerizations between TEGDMA and bisGMA that heterogeneous and poorly ⁇ packed polymer networks result, due to TEGDMA’s tendency to cyclization, as well as bisGMA’s rigidity [Pfeifer et al., Eur Polym J. 2011;47:162 ⁇ 70].
- Cyclization is likely in difunctional molecules with flexible backbones, ultimately leading to the formation of a network with reduced cross ⁇ linking density and glass transition temperature, despite the high levels of final degree of conversion [Anhseth et al., Chemical Engineering Science. 1994;49:2207 ⁇ 17; Elliot et al., Dental Materials. 2001;17:221 ⁇ 9; and Boots et al., Polymer Bulletin. 1984;11:415 ⁇ 20].
- the flexibility of the pendant groups and crosslinks make the TEGDMA molecule susceptible to rotational motion and with tendency to occupy more space, which compromises the packing efficiency and increases the free volume [Pfeifer et al., Eur Polym J. 2011;47:162 ⁇ 70].
- HEMAM Hy does not contain any substituents, and its polymerization reaction took place at slow rates which, in tandem with the potential phase separation indicated by the double ⁇ staged kinetic profile, may have led to toughening of the material, as previously demonstrated [Naficy et al., Journal of Applied Polymer Science. 2013;130:2504 ⁇ 13].
- bars were prepared for dynamic mechanical analysis test, but the experiment was not conducted because, after the post ⁇ curing heat processing necessary prior to the DMA test (16 hours at 180°C), the bars of HEMAM Hy, 2EM and 2dMM groups became too brittle and showed evidence of significant internal cracking (Figure 8).
- Embodiment 1 provides a dental adhesive composition comprising one or more monomer compounds selected from the group of:
- Embodiment 2 provides a dental adhesive composition comprising one or more monomer compounds selected from the group of:
- Embodiment 3 provides a dental adhesive composition comprising one or more monomer compounds selected from the group of:
- Embodiment 4 provides a dental adhesive composition comprising one or more monomer compounds selected from the group of:
- Embodiment 5 provides a dental adhesive composition comprising one or more monomer compounds selected from the group of: .
- Embodiment 21 comprises the dental adhesive composition of any of Embodiments 1 through 20, further comprising a co ⁇ monomer compound selected from the group of bisphenol A diglycidyl ether dimethacrylate (BisGMA), triethylene glycol dimethacrylate (TEGDMA), urethane dimethacrylate (UDMA), ethylene glycol dimethylacrylate (EGDMA), ethane ⁇ 1,2 ⁇ diyl bis(2 ⁇ methylacrylate) (PEGDMA), ethoxylated bisphenol A dimethacrylate (EBPADMA), ethylene glycoldi(meth)acrylate, hexanediol di(meth)acrylate, tripropylene glycol di(meth)acrylate, butanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, diethylene glycoldi(meth)acrylate, diethylene glycoldi(meth)acrylate, hexanediol di
- Embodiment 22 comprises the dental adhesive composition of Embodiment 21, wherein the co ⁇ monomer compound is BisGMA.
- Embodiment 23 comprises the dental adhesive composition of Embodiment 21, wherein the co ⁇ monomer compound is TEGDMA.
- Embodiment 24 comprises the dental adhesive composition of Embodiment 21, wherein the co ⁇ monomer compound is UDMA.
- Embodiment 25 comprises the dental adhesive composition of Embodiment 21, wherein the co ⁇ monomer compound is EGDMA.
- Embodiment 26 comprises the dental adhesive composition of Embodiment 21, wherein the co ⁇ monomer compound is PEGDMA.
- Embodiment 27 comprises the dental adhesive composition of any of Embodiments 21 through 26, wherein: a) the relevant one or more monomers indicated in Embodiments 1 through 20 comprise from about 35% to about 45%, by weight, of the dental adhesive composition; and b) the relevant co ⁇ monomer compound indicated in Embodiments 21 through 26 comprises from about 55% to about 65%, by weight, of the composition.
- Embodiment 28 comprises the dental adhesive composition of any of Embodiments 21 through 26, wherein: a) the relevant one or more monomers indicated in Embodiments 1 through 20 comprise from about 37% to about 43%, by weight, of the dental adhesive composition; and b) the relevant co ⁇ monomer compound indicated in Embodiments 21 through 26 comprises from about 57% to about 63%, by weight, of the composition.
- Embodiment 29 comprises the dental adhesive composition of any of Embodiments 1 through 28, wherein the dental adhesive composition further comprises a photoinitiator.
- Embodiment 30 comprises the dental adhesive composition of Embodiments 29, wherein the photoinitiator or polymerization initiator is selected from the group of camphorquinone (CQ); trimethylbenzoyl ⁇ diphenyl ⁇ phosphine oxide (TPO); Ethyl ⁇ 4 ⁇ dimethylamino benzoate (EDMAB); 2,2 ⁇ Dimethoxy ⁇ 2 ⁇ phenylacetophenone (DMPA); Bisacylphosphine oxide (BAPO); 1 ⁇ Phenyl ⁇ 1,2 ⁇ propanedione (PPD); phosphine oxide compounds, including naphthacene (APO), 9 ⁇ anthracene (APO), and; 1 ⁇ phenyl ⁇ 1,2 ⁇ propanedione (PPD); thioxanthone (TX) and its derivatives; dibenzoyl germanium derivatives, such as benzoyltrimethylgermane (BTG) and dibenzoyldiethylgermane; hexaarylbiimi
- Embodiment 31 comprises the dental adhesive composition of any of Embodiments 29 and 30, wherein the photoinitiator or polymerization initiator is selected from the group of 2,2 ⁇ Dimethoxy ⁇ 2 ⁇ phenylacetophenone (DMPA), diphenyliodonium hexafluorophosphate, and (diethylgermanediyl)bis((4 ⁇ methoxyphenyl)methanone) (Ivocerin), or a combination thereof.
- DMPA 2,2 ⁇ Dimethoxy ⁇ 2 ⁇ phenylacetophenone
- Ivocerin diethylgermanediyl
- Embodiment 32 comprises the dental adhesive composition of any of Embodiments 29, 30, and 31, wherein the photoinitiator or polymerization initiator is selected from the group of 2,2 ⁇ Dimethoxy ⁇ 2 ⁇ phenylacetophenone (DMPA) and diphenyliodonium hexafluorophosphate, or a combination thereof.
- DMPA 2,2 ⁇ Dimethoxy ⁇ 2 ⁇ phenylacetophenone
- diphenyliodonium hexafluorophosphate or a combination thereof.
- Embodiment 33 comprises the dental adhesive composition of any of Embodiments 29, 30, 31, and 32, wherein the composition further comprises a chemical inhibitor/stabilizer/free radical scavenger selected from the group of butylated hydroxytoluene (BHT), hydroquinone, 2,5 ⁇ di ⁇ tert ⁇ butyl hydroquinone, monomethyl ether hydroquinone (MEHQ), and 2,5 ⁇ di ⁇ tertiary butyl ⁇ 4 ⁇ methylphenol, 3,5 ⁇ di ⁇ tert ⁇ butyl ⁇ 4 ⁇ hydroxyanisole (2,6 ⁇ di ⁇ tert ⁇ butyl ⁇ 4 ⁇ ethoxyphenol), 2,6 ⁇ di ⁇ tert ⁇ butyl ⁇ 4 ⁇ (dimethylamino)methylphenol or 2 ⁇ (2′ ⁇ hydroxy ⁇ 5′ ⁇ methylphenyl) ⁇ 2H ⁇ benzotriazole, 2 ⁇ (2′ ⁇ hydroxy ⁇ 5′ ⁇ t ⁇ octylphenyl) ⁇ 2H ⁇ benzotriazole, 2 ⁇ (2′ ⁇ hydroxy ⁇ 4′,6′ ⁇
- Embodiment 34 comprises the dental adhesive composition of Embodiment 33, wherein the composition comprises a chemical inhibitor/stabilizer/free radical scavenger at a concentration of from about 0.01% to about 0.5%, by weight.
- Embodiment 35 comprises the dental adhesive composition of any of Embodiments 33 and 34, wherein the composition comprises a chemical inhibitor/stabilizer/free radical scavenger at a concentration of from about 0.05% to about 0.3%, by weight.
- Embodiment 36 comprises the dental adhesive composition of any of Embodiments 33, 34, and 35, wherein the composition comprises a chemical inhibitor/stabilizer/free radical scavenger at a concentration of from about 0.05% to about 0.2%, by weight.
- Embodiment 37 comprises the dental adhesive composition of any of Embodiments 33, 34, 35, and 36, wherein the composition comprises a chemical inhibitor/stabilizer/free radical scavenger is butylated hydroxytoluene (BHT).
- Embodiment 38 comprises the dental adhesive composition of any of Embodiments 1 through 37, wherein the dental adhesive composition further comprises a self ⁇ etching agent.
- Embodiment 39 comprises the dental adhesive composition of Embodiment 38, wherein the self ⁇ etching agent comprises a carboxylic acid, phosphonic acid, or phosphate groups
- Embodiment 40 comprises the dental adhesive agent of any of Embodiments 38 and 39, wherein the self ⁇ etching agent is selected from the group of 10 ⁇ methacryloyloxydecyl dihydrogen phosphate (10 ⁇ MDP or MDP, CAS Reg. No.
Abstract
The present invention concerns amine-terminated and methacrylate/methacrylamide monomers for dental applications, particularly including dental adhesives. Some embodiments comprise photocurable compositions.
Description
DENTAL ADHESIVES FORMULATED WITH SECONDARY METHACRYLAMIDES FIELD OF THE INVENTION The present invention concerns amine‐terminated and methacrylate/methacrylamide monomers for dental adhesive applications. STATEMENT OF GOVERNMENT SUPPORT This invention was made with government support under 1U01‐DE023756, 1R01‐DE026113, K02‐ DE025280; R01‐DE028757; and R35‐DE029083 awarded by NIH‐NIDCR. The government has certain rights in the invention. BACKGROUND OF THE INVENTION Dental adhesive interfaces with reduced susceptibility to degradation could lead to dental restorations with extended clinical lifetimes. Degradation is the result of two factors: (1) collagen degradation by endogenous proteases [ Mazzoni et al., Endodontic Topics. 2009;21:19‐40], [ Tjäderhane et al., Dent Mater. 2013;29:116‐35], and (2) polymer hydrolysis. The hydrolysis of dental adhesives – specifically the ester functionality within the polymer – is catalyzed by acid (low pH) as well as bacterial/salivary esterases [Santerre et al., Critical Reviews in Oral Biology & Medicine. 2001;12:136‐ 51], [Tay et al., Journal of Dentistry. 2004;32:611‐21], [ Finer et al., Journal of Biomaterials Science, Polymer Edition. 2003;14:837‐49], [Huang et al., Acta Biomaterialia. 2018;71:330‐8]. A host of strategies have been suggested to achieve a more stable dental adhesive interface to promote longer clinical lifetimes, including the use of compounds shown to reduce the activity of the metalloproteinases and cysteine cathepsins responsible for the proteolysis of collagen fibrils [Loguercio et al., European journal of oral sciences. 2009;117:587‐96], [Gendron et al., Clin Diagn Lab Immunol. 1999;6:437‐9], [Scaffa et al., Journal of dental research. 2012;91:420‐5], [Perchyonok T, Grobler SR, Zhang S, Olivier A, Oberholzer T. Insights into chitosan hydrogels on dentine bond strength and cytotoxicity. 2013], [Carrilho et al., Journal of dental research. 2007;86:529‐33]. One common example is chlorhexidine digluconate, but this compound shows cytotoxicity, high water solubility, low substantivity and only short‐term effects [Karpiński et al., Eur Rev Med Pharmacol Sci. 2015;19:1321‐6], [Frassetto et al., Dental Materials. 2016;32:e41‐e53], [Hashimoto et al., Journal of Dental Research. 2000;79:1385‐91], [ Komori et al., Operative Dentistry. 2009;34:157‐65], [ Ricci et al., European Journal of Oral Sciences. 2010;118:411‐6]. Another strategy relies on the dentin biomodification by flavonoid‐type polyphenolics (such
as proanthocyanidins, quercetin, and curcumin) or 1‐Ethyl‐3‐(3‐dimethylamino‐propyl) carbodiimide (EDC), which may function as collagen cross‐linking agents and inhibit the activity of the endopeptidases [ Frassetto et al., Dental Materials. 2016;32:e41‐e53], [Porto et al., European Journal of Oral Sciences. 2018;126:146‐58], [Betancourt et al., Int J Biomater. 2019;2019:5268342‐], [Hass et al., Dental Materials. 2016;32:732‐41], [Seseogullari‐Dirihan et al., Dental Materials. 2016;32:423‐ 32], [Bedran‐Russo et al., Journal of Biomedical Materials Research Part B: Applied Biomaterials: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials. 2007;80:268‐72]. The undesirable effects of staining dentin along with the uncertain longevity of the benefits make the clinical feasibility of this approach questionable. Another recent strategy to improve dental adhesive performance is the use of hydrolysis‐ resistant compounds. After more than 60 years using purely methacrylate‐based compositions, researchers have concentrated their efforts on the inclusion of more hydrolytically stable compounds as co‐monomers for dental adhesives. Methacrylamide‐methacrylate blends have emerged as materials with significantly improved properties [Fugolin et al., Dental Materials. 2019;35:686‐96], [Rodrigues et al., Dental Materials. 2018;34:1634‐44], [Salz et al., J Adhes Dent. 2005;7:107‐16], [Moszner et al., Macromolecular Materials and Engineering. 2016;301:750‐9]. The replacement of the oxygen atom in the ester group of hydroxyethylmethacrylate (HEMA) by an NH (amide group) resulted in formulations with markedly higher bond stability, which was mainly attributed to the replacement of ester bonds with amide bonds, making the polymers more resistant to hydrolysis [Nishiyama et al., Journal of Dental Research. 2001;80:855‐9]. Methacrylamide‐based polymer performance is highly dependent on the chemical structure localized about the amide functional group. For example, α‐substituted secondary methacrylamides (40% weight blend in methacrylates) lead to materials with more stable mechanical adhesion after 6 months than unsubstituted secondary methacrylamides [Fugolin et al., Dental Materials. 2019;35:686‐96]. However, the degree to which the side‐group substituents affect polymerization kinetics and subsequent polymer stability (hydrolysis kinetics) is not well understood for methacrylamides, especially in comparison with methacrylates. Further, the effects that α‐ and β‐carbon substituents have on hydrolysis in materials remain unexplored. Based on homogenous chemical model systems, the maximum expected effect of the substitution on the hydrolysis rates of amides is ten times slower (i.e., ten times longer lifetime) compared to esters [Bender et al., Journal of the American Chemical Society. 1958;80:1044‐8], and a maximum factor of ∼2.5 slower hydrolysis is expected for sterically imposing side‐chains [Charton et al.,
Journal of Organic Chemistry. 1978;43:3995‐4001] – see Scheme 1 in supplemental materials. This sterically derived hydrolytic stability factor is approximately the same for both ester and amide hydrolysis. Thus, additional hydrolytic stability could be imparted to the material both at the ester and the amide groups by the synthetic inclusion of chemically inert methyl groups. Based on homogenous chemical model systems, the maximum expected effect of the substitution on the hydrolysis rates of amides is ten times slower (i.e., ten times longer lifetime) compared to esters [Bender et al., Journal of the American Chemical Society. 1958;80:1044‐8], and a maximum factor of ∼2.5 slower hydrolysis is expected for sterically imposing side‐chains [Charton et al., Journal of Organic Chemistry. 1978;43:3995‐4001] – see Scheme 1 in supplemental materials. This sterically derived hydrolytic stability factor is approximately the same for both ester and amide hydrolysis. Thus, additional hydrolytic stability could be imparted to the material both at the ester and the amide groups by the synthetic inclusion of chemically inert methyl groups. One important point to consider is that the same factors that make amide bonds more stable than acrylate bonds also affect polymerization rate (Scheme 2 in supplemental materials). Neat methacrylamides tend to have slower polymerization kinetics compared to methacrylates [Barcelos et al., Dental Materials. 2020;36:468‐77] because the vinyl radical that is generated during the polymerization is better resonance stabilized by the amide nitrogen in a non‐propagating form (Scheme 2 in supplemental materials) than an analogous ester oxygen. The difference in resonance forms makes the vinyl amide radical more stable and subsequently, less reactive than the less stable and more reactive methacrylate radical. In addition, (meth)acrylamides are more prone to water sorption, and therefore, are expected to lead to a reduction in bulk mechanical properties after exposure to the oral environment [Fugolin et al., Dental Materials. 2019;35:1378‐87]. To overcome these limitations, methacrylamide‐methacrylate co‐polymerizations can lead to significant gains in dentin bond strength stability, while only marginally affecting polymerization rate [Fugolin et al., Dental Materials. 2019;35:686‐96]. It is currently unclear how methylation as mentioned above affects the polymerization kinetics and the final material properties and there remains a need for more stable dental adhesives. SUMMARY OF THE INVENTION Ester‐free monomers have been suggested as more stable alternatives for dental adhesives. Specifically, alpha and beta‐carbon substitutions have been shown to slow down degradation of polymeric
networks. The new class of monomers described here comprises systematic variations of mono and hybrid difunctional methacrylate/methacrylamides with alkyl chains being used as substitutions on the alpha or beta positions in relation to the polymerizable group. Monofunctional monomers are shown in Figure 1 and hybrid monomers are shown in Figure 2. All monomers have been synthesized, and selected monomers have been evaluated in terms of kinetics of polymerization and long‐term microtensile bond strength as part of the formulation of dental adhesives. One embodiment herein provides a dental adhesive composition comprising one or more of: a) a hydroxyl‐terminated methacrylamide compound selected from the group of:
b) a hydroxyl‐terminated methacrylate compound selected from the group of:
; or c) an amino‐terminated methacrylate compound selected from the group of:
; or d) a di‐functional methacrylamide/methacrylate compound selected from the group of:
. BRIEF DESCRIPTION OF THE DRAWINGS FIGURE 1 presents a bar graph of the percentage degree of conversion for three tested monomers. FIGURE 2 presents a line graph representing kinetics of polymerization curves (average of three curves) for six tested monomers. FIGURE 3 presents a line graph representing kinetics of polymerization results at 50 °C for HEMA, HEMAM and 2‐methyl HEMAM. FIGURE 4 presents a bar graph representing the shear storage modulus values determined for the hybrids HEMAM Hy and 2dMM Hy. FIGURE 5 presents a table of half‐lives for monomers in acidic aqueous conditions at 37°C (data were fit to an exponential decay model). FIGURE 6 depicts steric interactions of α‐carbon alkyl substituents have been shown to cause 2° and 3° amides to twist about the C‐N bond. FIGURE 7 presents bar graphs comparing water sorption and solubility determined for tested monomers. FIGURE 8 presents images of comparative cracking in tested polymers. FIGURE 9 presents line graphs representing the kinetics curves profiles of HEMA, HEMAM and HEMAM Hy. FIGURE 10 presents a table of %DC at inflection of a deceleration curve for HEMA, HEMAM, and HEMAN Hy. DETAILED DESCRIPTION OF THE INVENTION
Other embodiments, provide a composition comprising a compound selected from groups a)‐d) above and one or more comonomers selected from the group of bisphenol A diglycidyl ether dimethacrylate (BisGMA), triethylene glycol dimethacrylate (TEGDMA), urethane dimethacrylate (UDMA), ethylene glycol dimethylacrylate (EGDMA), ethane‐1,2‐diyl bis(2‐methylacrylate) (PEGDMA), ethoxylated bisphenol A dimethacrylate (EBPADMA), ethylene glycoldi(meth)acrylate, hexanediol di(meth)acrylate, tripropylene glycol di(meth)acrylate, butanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, dipropylene glycol di(meth)acrylate, allyl (meth)acrylate, 1,6‐hexanediol dimethacrylate (HEDMA), 1,6‐ hexamethylene glycol dimethacrylate (HGDMA), divinyl benzene and derivatives thereof. In some embodiments, the co‐monomer or co‐monomers selected from this group comprises from about 55% to 65% of the composition, by weight. Still other embodiments provide such compositions comprising at least one monomer and one co‐monomer, as described herein, and further comprising a polymerization initiator, such as one selected from the group of camphorquinone (CQ); trimethylbenzoyl‐diphenyl‐phosphine oxide (TPO); Ethyl‐4‐dimethylamino benzoate (EDMAB); 2,2‐Dimethoxy‐2‐phenylacetophenone (DMPA); Bisacylphosphine oxide (BAPO); 1‐Phenyl‐1,2‐propanedione (PPD); phosphine oxide compounds, including naphthacene (APO), 9‐anthracene (APO), and bisacylphosphine oxide (BAPO); 1‐phenyl‐1,2‐ propanedione (PPD); thioxanthone (TX) and its derivatives; a dibenzoyl germanium derivative, benzoyltrimethylgermane (BTG), dibenzoyldiethylgermane; hexaarylbiimidazole derivatives; a silane based derivative; (diethylgermanediyl)bis((4‐methoxyphenyl)methanone); benzenesulfinic acid sodium salt (BS); a diaryliodonium salt, diphenyliodonium chloride or iodonium salt [diphenyliodonium hexafluorophosphate (DPIHP or DPI‐PF6))], bromide, iodide, or hexafluorophosphate; benzoyl peroxide (BPO), and ethyl 4‐N,N‐dimethaminobenzoate. In further embodiments, the polymerization initiator is a combination of initiators, such as those selected from the group of camphorquinone/ethyl‐4‐ (dimethylamino)benzoate (EDMAB), camphorquinone/2‐(dimethylamino)ethyl methacrylate (DMAEMA)), DMPA/DPI‐PF6, CQ/PPD, CQ/DMAEMA, CQ/EDMAB, CQ/DMAEMA/PDIHP, or CQ/EDMAB/DPIHP. In some embodiments, the polymerization initiator one or both of the group DMPA and DPI‐PF. In some embodiments, the polymerization initiator comprises from about 0.05% to about 0.6% of the composition, by weight. In some embodiments, the composition also comprises a chemical inhibitor (also referred to as a stabilizer or free radical scavengers ), such as one selected from the group of butylated
hydroxytoluene (BHT), hydroquinone, 2,5‐di‐tert‐butyl hydroquinone, monomethyl ether hydroquinone (MEHQ), and 2,5‐di‐tertiary butyl‐4‐methylphenol, 3,5‐di‐tert‐butyl‐4‐hydroxyanisole (2,6‐di‐tert‐butyl‐ 4‐ethoxyphenol), 2,6‐di‐tert‐butyl‐4‐(dimethylamino)methylphenol or 2‐(2′‐hydroxy‐5′‐methylphenyl)‐ 2H‐benzotriazole, 2‐(2′‐hydroxy‐5′‐t‐octylphenyl)‐2H‐benzotriazole, 2‐(2′‐hydroxy‐4′,6′‐di‐tert‐ pentylphenyl)‐2H‐benzotriazole, 2‐hydroxy‐4‐n‐octoxybenzophenone, 2‐(2′‐hydroxy‐5′‐methacryloxy‐ ethylphenyl)‐2H‐benzotriazole, phenothiazine, and HALS (hindered amine light stabilizers). The compositions may also comprise an ultraviolet light (UV) absorber, such as 2‐hydroxy‐4‐ methoxybenzophenone (UV‐9), 2‐(2‐Hydroxy‐5‐octylphenyl)‐benzotriazole (UV‐5411), salicylic acid phenyl ester, 3‐(2′‐hydroxy‐5′‐methylphenyl)benzotriazole, and 2‐(2'‐hydroxy‐5'‐methylphenyl)‐ benzotriazole. The UV absorber may be present in the composition at from about 0.001% to about 0.5%, by weight. In some embodiments the chemical inhibitor is incorporated into the composition at a concentration of from about 0.01% to about 0.5%, by weight. In other embodiments, the chemical inhibitor is present in the composition at from about 0.05% to about 0.3%, by weight. In still other embodiments, the chemical inhibitor is present in the composition at from about 0.05% to about 0.2%, by weight. In additional embodiments, the chemical inhibitor is present in the composition at from about 0.05% to about 0.15%, by weight. It is understood that the compositions herein may include further elements, such as a fluorescent agent, a fluoride releasing agent, a radiopaque agent, a flavoring agent, and an antimicrobial agent. Purpose/aim: Ester‐free monomers have been suggested as more stable alternatives for dental adhesives. Specifically, alpha and beta‐carbon substitutions have been shown to slow down degradation of polymeric networks. The aim of this study was to evaluate kinetics of polymerization and long‐term microtensile bond strength of dental adhesives formulated with novel secondary methacrylamides. Materials and methods: Secondary methacrylamides with different carbon substitutions (alpha ‐ 2MM, beta ‐ 3MM and no substitution ‐ HEMAM) were copolymerized with UDMA at 40/60 mass ratio. 0.2 wt% DMPA and 0.4 wt% DPI‐PF6 were used as photoinitiators. Polymerization kinetics was followed with near‐ IR in real‐time (6165‐6135 cm−1) for 300s at 800 mW/cm2 (320–500 nm). Solvated adhesives (40 vol% ethanol) were used to bond composite (Filtek Supreme) to flat human dentin surfaces, and compared with Adper Single Bond (3M). Dentin microtensile bond strength (µTBS) was measured on sticks (1mm2)
after 24 h and 6 months storage in water at 37 °C. Results were analyzed with one‐way ANOVA/Tukey's test (α=0.05). Results: Chemical structures, degree of conversion (DC, grey line) (%) and µTBS (MPa) are shown in Fig. 1. DC was similar for HEMAM and 2MM (89.9% and 86.6%, respectively) and higher than 3MM (66.0%), likely due to higher viscosity of 3MM, which forms a gel‐like mixture with UDMA at room temperature. At 24h, µTBS was similar for all groups (p = 0.063). After 6‐months, 2MM showed the highest and 3MM the lowest values (42.9 and 33.0 MPa, respectively). The dental adhesive compositions herein may include one or more photoinitiator agents. The term “initiator” or “polymerization initiator” herein refers to thermal initiating, redox‐initiating, and/or photoinitiating compounds capable of inducing polymerization throughout a significant depth of composite material, such as camphorquinone (CQ); trimethylbenzoyl‐diphenyl‐phosphine oxide (TPO); Ethyl‐4‐dimethylamino benzoate (EDMAB); 2,2‐Dimethoxy‐2‐phenylacetophenone (DMPA); Bisacylphosphine oxide (BAPO); 1‐Phenyl‐1,2‐propanedione (PPD); phosphine oxide compounds, including naphthacene (APO), 9‐anthracene (APO), and bisacylphosphine oxide (BAPO); 1‐phenyl‐1,2‐ propanedione (PPD); thioxanthone (TX) and its derivatives; dibenzoyl germanium derivatives, such as benzoyltrimethylgermane (BTG) and dibenzoyldiethylgermane; hexaarylbiimidazole derivatives; silane based derivatives; (diethylgermanediyl)bis((4‐methoxyphenyl)methanone) (Ivocerin); benzenesulfinic acid sodium salt (BS); diaryliodonium salts (such as diphenyliodonium chloride or iodonium salt [diphenyliodonium hexafluorophosphate (DPIHP, DPI‐PF6, or DPI‐PF6))], bromide, iodide, or hexafluorophosphate; and benzoyl peroxide (BPO). It is understood that in the compositions herein, one initiator material may be used or 2 or more may be used, such as the combination of camphorquinone with a co‐initiator, such as a tertiary amine initiator (such as ethyl‐4‐(dimethylamino) benzoate (EDMAB) and/or 2‐(dimethylamino)ethyl methacrylate (DMAEMA)), or a combination of DMPA/DPI‐PF6, CQ/PPD, CQ/DMAEMA, CQ/EDMAB, CQ/DMAEMA/PDIHP, or CQ/EDMAB/DPIHP. Commercially available photoinitiators for use with the present compositions include monoacylphoshine oxide (MAPO, available from Lucirin TPO, BASF), bisacylphosphine oxide (BAPO, Irgacure 819, Ciba Geigy), phenylpropanedione (PPD, Aldrich), and camphorquinone (CQ, Aldrich). Tested Co‐monomers
The commercially‐available monomers used in this study were purchased from Sigma Aldrich (Milwaukee, WI, USA) at 95% or greater purity, and used as received: 2‐hydroxyethyl methacrylate – HEMA, 2‐hydroxyethyl methacrylamide – HEMAM, 2‐hydroxy‐2‐methylethyl methacrylamide – 2‐methyl HEMAM. Hydroxypropyl methacrylate was obtained as a mixture of isomers consisting of the α‐ substituted 2‐hydroxy‐1‐methylethyl methacrylate – 1‐methyl HEMA, and β‐substituted 2‐hydroxy‐2‐ methylethyl methacrylamide – 2‐methyl HEMA. The composition of the mixture was determined by 1H NMR spectroscopy to be 72% 2‐methyl HEMA and 28% 1‐methyl HEMA, consistent with the distributer's analysis. The hydroxypropyl methacrylate isomeric mixture was used as received due to facile isomerization equilibrium (discussed later). 2‐hydroxy‐1‐methylethyl methacrylamide – 1‐methyl HEMAM was synthesized de novo (see supplementary information). The structures of all monomers used in this study are shown below. Hydroxyl‐Terminated Methacrylamides
Hydroxyl‐Terminated Methacrylates
Amino‐Terminated Methacrylates
The monomers above may be copolymerized with monomers, particularly dental resin monomers (UDMA, BisGMA, etc.), in dental adhesive compositions. The NH2‐terminated methacrylate used in this study (2‐aminoethyl methacrylate (AEMA) was obtained as a hydrochloride salt. The α‐substituted, 2‐amino‐1‐methylethyl methacrylate – 1‐methyl AEMA, and the β‐substituted, 2‐amino‐2‐methylethyl methacrylate – 2‐methyl AEMA, amino‐terminated monomers were synthesized as hydrochloride salts following procedures adapted from a previous report [31]. Detailed information can be found in the supplementary information. In order to prevent the confounding variable of the presence of a salt in the polymer formulations, the hydrochloride salts were neutralized prior to formulation of the tested materials. Formulations and photocuring conditions The co‐monomers were mixed at 40 wt% with UDMA (urethane dimethacrylate, purchased from ESSTECH, Essington, PA, USA). The mixtures were made polymerizable by the addition of 0.2 wt% DMPA (2,2‐dimethoxy‐2‐phenyl acetophenone) and 0.4 wt% DPI‐PF6 (diphenyliodonium hexafluorophosphate). BHT (butylated hydroxytoluene) was incorporated at 0.1 wt% into the formulations as an inhibitor. All photocuring procedures were carried out with a mercury arc lamp (Acticure 4000, 320–500 nm filtered) at 630 mW/cm2 measured directly on the surface of the samples using a power meter (PowerMax 5200, Molectron Detector Inc., Portland, OR, USA). Kinetics of polymerization Polymerization kinetics were followed with real time by near‐IR spectroscopy. Discs of 6 mm diameter and 0.8 mm thickness were sandwiched between glass slides and photoactivated for 300 s with the tip of the light guide placed 4 cm away and perpendicular to the glass surface, delivering 630 mW/cm2 at the sample surface (n = 3). Spectra were collected for 330 s, with 2 scans per spectrum at 4 cm−1 resolution. The light was kept on for the duration of the experiment to provide isothermal conditions, and avoid overestimation of conversion due to potential IR pathlength reduction (had the light been turned off during the experiment, causing shrinkage of the specimen). The followed peaks were 6165 and 6135 cm−1 for methacrylates and methacrylamides, respectively. The maximum rate of polymerization (RPMAX) was calculated as the first derivative of the degree of conversion vs. time curve, and the final degree of conversion (Final DC) was based on the change in area of the vinyl overtone
peaks. The degree of conversion at the maximum rate of polymerization (DC at RPMAX) was used as a proxy for the onset of vitrification. Since the β‐substituted secondary methacrylamide 2‐methyl AEMA was not soluble in the organic matrix at room temperature, the mixture was heated on a hot plate to 50 °C and the kinetics tested immediately at the same conditions described above. For an appropriate comparison, the methacrylamide and methacrylate controls – HEMAM and HEMA, were also tested at 50˚C, as controls. Formulations that did not cure or cured very slowly were not subjected to dentin microtensile bond strength or monomer hydrolysis kinetics. Dentin microtensile bond strength Sound human dentin from extracted third molars was used as the substrate for microtensile bond strength (μTBS) (project approved by Oregon Health & Science University – IRB #00012056). Ethanol was added at 40 vol% to the selected monomer compositions. Briefly, enamel was removed to expose a flat surface of mid‐coronal dentin. A smear layer was created on this surface using 600 grit sandpaper for 30 s followed by etching with 35% phosphoric acid (3M ESPE, St. Paul, MN, USA) for 15 s and rinsing for 10 s. After blotting the surface dry, two consecutive coats of the experimental adhesives were applied and solvent evaporated using a gentle air spray for 10 s. The second coat of the adhesive was photoactivated for 60 s with the light guide 4 cm away from the surface delivering 630 mW/cm2. The restorative procedures consisted of a composite block (Filtek Supreme, A2 – 3M ESPE, St. Paul, MN, USA) built in 2 increments of 2 mm thickness, photoactivated for 30 s each at 1100 mW/cm2 (Elipar DeepCure‐S, 3M ESPE, St. Paul, MN, USA). Adper Single Bond (composed of dimethacrylates and HEMA, 3M ESPE, St. Paul, MN, USA) was tested as commercial control and used as described previously except for the photoactivation of the second coat, carried out for 20 s using Elipar (Mono‐wave LED, 3M‐ESPE) at 1100 mW/cm2 placed directly over the dentin surface (n = 6). All experimental adhesives, including the experimental control, were photoactivated with light parameters that were optimized for the type and concentration of initiator (DMPA/DPI = PF6, λmax = 365 nm), as determined in a preliminary study. The commercial control was included as an external benchmark, and photoactivated according to manufacturer's instructions using a commercially available light source. After 24 h, the teeth were cut on a slow speed diamond saw to obtain 1 mm2 transversal section area sticks, which were stored for an additional 24 h or 6 months in distilled water at 37 °C. At the end of the storage time, sticks were fixed to a custom‐made metal jig (Odeme Equipment, Luzerna, SC, Brazil) using super glue (Zapit, Dental
Ventures of America Inc, Corona, CA, US), attached to a universal testing machine (Criterion MTS, Eden Prairie, MN, USA), and tested until failure at 0.5 mm/min. Monomer hydrolysis kinetics An aqueous solution (H2O, pH = 1) was prepared using HPLC grade water and adjusted using 1.0 M HCl. A 50 mM solution of each monomer (n = 3) was prepared using 1.0 mL of the acidic aqueous solution. A capillary tube was filled with a 50 mM solution of tetramethylammonium bromide dissolved in D2O and flame sealed. The capillary tube was placed at the bottom of the NMR tube to allow the locking of the magnet on the instrument onto the deuterium of the inner‐tube with the ammonium acting as an internal standard. 1H NMR spectra were obtained using a water suppression by excitation sculpting experiment [Mobarhan et al., Analytical and Bioanalytical Chemistry. 2017;409:5043‐55]. After the initial reading, the NMR tubes were flame sealed and incubated at 37 °C. At 4, 9, and 17 days (4, 7, 12, and 19 days for HEMA), the samples were removed from incubation to obtain water suppressed 1H NMR spectra. To determine the amount of monomer degradation, spectra were first aligned using the ITSD singlet peak and then an integration region unique to vinyl protons of the monomer, methacrylic acid, and transesterification product (if applicable) were compared to calculate the percentage of intact monomer. To determine the rate constant and half‐lives for the hydrolysis of each monomer, data were fit to a pseudo‐first order exponential decay function (Eq. (1)) where A is the percentage of intact monomer, A0 is the initial monomer purity (>99%), and t is time in days. (1) A=A0e−kt Statistical analysis Data were statistically analyzed with one‐way ANOVA and Tukey's test (α = 0.05), after normality and homoscedasticity tests. Student's T‐test was carried out to analyze the effect of the storage time on the μTBS (α = 0.05). Polymerization kinetics Kinetics of polymerization results for the groups tested at room temperature are shown in Fig. 2 and Table 1. The OH‐terminated methacrylate, HEMA α‐,β‐CH3 mixture showed the highest RPMAX, 20.2%∙s−1, and the NH2‐terminated 1‐methyl and 2‐methyl AEMA the lowest at 5.3%∙s−1. The
methacrylamides, HEMAM and 1‐methyl HEMAM, presented intermediate RPMAX values: 13.0 and 13.3%.s−1, respectively. The DC at RPMAX ranged between 35.1% and 16.7%. In general, OH‐ terminated methacrylates showed the highest values (35.1% and 31.6% for HEMA and HEMA α‐,β‐ CH3 mixture, respectively), followed by the methacrylamides (22.2% and 24.3% for HEMAM and 1‐ methyl HEMAM, respectively). The NH2‐terminated 1‐methyl and 2‐methyl AEMA presented the lowest values: 15.7% and 16.7%, respectively. Final DC values ranged between 94.0% and 79.0%, with HEMA and 2‐methyl AEMA presenting the highest and the lowest values, respectively. All other groups were statistically similar to each other. The non‐substituted NH2‐terminated AEMA did not polymerize. Fig. 2. Depicts degree of conversion (%) as a function of time (s), and polymerization rate (%∙s−1) as a function of the degree of conversion (%) for all tested copolymers containing UDMA as base monomer. The kinetics of polymerization was followed at room temperaure in real time by near‐IR spectroscopy during photopolymerization for 300 s at 630 mW/cm2. Table 1. Average (standard deviation) for maximum rate of polymerization (RPMAX – %∙s−1), degree of conversion at the maximum rate of polymerization (DC at (RPMAX – %) and final degree of conversion (Final DC – %) for all tested copolymers. Values followed by different letters indicate significant differences among the tested groups (p < 0.05).
Kinetics of polymerization results at 50 °C for HEMA, HEMAM and 2‐methyl HEMAM are presented in Fig. 3 and Table 2. While there was no statistical difference among the tested groups in terms of RPMAX (values ranged between 16.1 and 18.1%∙s−1), the methacrylate control HEMA showed the highest values, 41.7% and 92.0%, for DC at RPMAX and final DC, respectively, and the non‐substituted HEMAM and the β‐substituted 2‐methyl HEMAM methacrylamides presented the lowest values of DC at RPMAX, 29.6% and 31.3%, respectively, and final DC, 86.3% and 86.6%, respectively. Fig. 3. Depicts degree of conversion (%) as a function of the time (s) and polymerization rate (%∙s−1) as a function of the degree of conversion (%) for the OH‐ terminated methacrylate control HEMA, and the non‐substituted HEMAM and the β‐substituted 2‐methyl HEMAM methacrylamides heated at 50 °C. The kinetics of polymerization was followed in real time by near‐IR spectroscopy during the photopolymerization for 300 s at 630 mW/cm2. Table 2. Maximum rate of polymerization (RPMAX – %∙s−1), degree of conversion at the maximum rate of polymerization (DC at (RPMAX – %) and final degree of conversion (Final DC – %) for the methacrylate and methacrylamide controls, and the β‐substituted methacrylamide 2‐methyl HEMAM. Values followed by different letters indicate significant difference among the tested groups (p < 0.05).
Dentin microtensile bond strength Dentin μTBS for the selected groups after 24 h and 6 months storage time are shown in Fig. 4. At 24 h, the commercial control Single Bond and the methacrylamides, HEMAM and the α‐substituted 1‐methyl HEMAM, showed the highest values (53.4 ± 9.8, 40.4 ± 5.9, and 45.5 ± 6.4 MPa, respectively), whereas HEMA α‐,β‐CH3 mixture presented the lowest bond strength (23.2 ± 6.8 MPa). After 6 months, Single Bond and 1‐methyl HEMAM presented the highest results (43.3 ± 5.3 and 42.9 ± 7.2 MPa, respectively). The methacrylates HEMA and HEMA α‐,β‐CH3 mixture presented the lowest values: 21.9 ± 5.2 MPa and
12.7 ± 3.2 MPa, respectively. The reduction in μTBS over time was statistically significant only for the HEMA α‐,β‐CH3 mixture, but all groups showed a numeric reduction ranging between 37.5% and 5.7% for HEMA and 1‐methyl HEMAM, respectively. Fig. 4. represents dentin microtensile bond strength after 24 h and 6 months aging for the selected groups. Different uppercase letters indicate significant difference among the groups at the same storage condition (p < 0.05), and different lowercase letters indicate significant difference between the storage conditions within the composition (p < 0.05). Monomer hydrolysis kinetics All tested monomers showed a measurable amount of degradation after 4 days or less exposure to acidic aqueous conditions (H
pH = 1) (Fig. 5). The unsubstituted methacrylamide, HEMAM, experienced the least degradation with 89.1 ± 0.01% of the monomer remaining intact after 17 days of incubation. The substituted methacrylamides, 2‐methyl HEMAM and 1‐methyl HEMAM, both exhibited more degradation than HEMAM, with 83.5 ± 0.5% and 65.4 ± 1.3% intact monomer remaining. The two methacrylate monomers exhibited similar degradation amounts, HEMA with 25.2 ± 0.1% intact monomer after 19 days incubation and the α,β‐CH3 HEMA mixture with 31.9 ± 0.4% intact monomer after 17 days incubation. The half‐life results from fitting to an exponential decay model and a transformed linear regression showed that HEMAM had the greatest half life at 104 days, nearly 10× longer than the α,β‐CH3 HEMA mixture (Figure 5). Additionally, transesterification products were observed in the methacrylamide groups. NMR spectra and further analysis can be found in the supplementary information. Fig. 5. Represents degradation of monomer over time in acid aqueous conditions (H2O, pH = 1) at 37 °C. NMR spectroscopy was used to determine the amount of remaining monomer compared to degradation products (and transesterification products where applicable). Error bars are too small to be seen. Data were fit to a pseudo‐first order exponential decay curve to determine monomer half‐life. Table 3. Half‐lives for monomers in acidic aqueous conditions at 37°C. Data were fit to an exponential decay model (Fig. 5) as well as linear regression using a natural logarithmic transformation.
Dynamic isomeric transesterification equilibrium The degradation of the adhesive interface is believed to be one of the most important causes of the reduced clinical lifetime of adhesive dental restorations. In addition to the collagen degradation, the hydrolysis of the polymeric constituents play a crucial role on the adhesive interface instability [3], [4], [5], [6], leading to the development of more degradation resistant monomers. The original experiment was designed to systematically evaluate the effect of the carbon substitutions on monomer reactivity and stability, in which alpha and beta‐substituted HEMA monomers would be tested individually. However, the systematic evaluation of the effect of the methyl substitutions for the HEMA derivatives was not possible due to the facile susceptibility to α and β‐CH3 isomerization. In fact, even the commercially available HEMA methylated derivative is only available as a mixture of isomers. This isomerization is very likely occurring via a low‐energy transesterification mechanism [33]. For example, the β‐substituted 1‐methyl HEMA is particularly susceptible to this isomerization. The terminal hydroxyl group participates in a transesterification resulting in a dimethacrylate and propane‐1,2‐diol (Scheme 3 in supplemental materials). Another transesterification occurs resulting in two monomethacrylates. In order to return to the original monomethacrylate, the secondary alcohol of the diol would need to participate in the transesterification while the more nucleophilic primary alcohol results in 2‐methyl
HEMA. This difference in nucleophilicity explains why an eventual equilibrium of a 3:1 ratio of 2‐methyl HEMA to 1‐methyl HEMA is reached in commercial HEMA α‐,β‐CH3. This transesterification will not result in an isomerization in unsubstituted monomers, like HEMA, though the dynamic behavior is likely still occurring. This mechanism explains the observation that the common impurities in commercial HEMA are dimethacrylate and ethylene glycol [34]. The degradation of the adhesive interface is believed to be one of the most important causes of the reduced clinical lifetime of adhesive dental restorations. In addition to the collagen degradation, the hydrolysis of the polymeric constituents play a crucial role on the adhesive interface instability [3], [4], [5], [6], leading to the development of more degradation resistant monomers. The original experiment was designed to systematically evaluate the effect of the carbon substitutions on monomer reactivity and stability, in which alpha and beta‐substituted HEMA monomers would be tested individually. However, the systematic evaluation of the effect of the methyl substitutions for the HEMA derivatives was not possible due to the facile susceptibility to α and β‐CH3 isomerization. In fact, even the commercially available HEMA methylated derivative is only available as a mixture of isomers. This isomerization is very likely occurring via a low‐energy transesterification mechanism [33]. For example, the β‐substituted 1‐methyl HEMA is shown as an example in Fig. 6 and is particularly susceptible to this isomerization. The terminal hydroxyl group participates in a transesterification resulting in a dimethacrylate and propane‐1,2‐diol (Scheme 3 in supplemental materials). Another transesterification occurs resulting in two monomethacrylates. In order to return to the original monomethacrylate, the secondary alcohol of the diol would need to participate in the transesterification while the more nucleophilic primary alcohol results in 2‐methyl HEMA. This difference in nucleophilicity explains why an eventual equilibrium of a 3:1 ratio of 2‐methyl HEMA to 1‐methyl HEMA is reached in commercial HEMA α‐,β‐CH3. This transesterification will not result in an isomerization in unsubstituted monomers, like HEMA, though the dynamic behavior is likely still occurring. This mechanism explains the observation that the common impurities in commercial HEMA are dimethacrylate and ethylene glycol [34]. A detailed exploration of this phenomenon is beyond the scope of this paper. Amino‐terminated methacrylates (AEMA, 1‐methyl AEMA, and 2‐methyl AEMA) were obtained or synthesized as hydrochloride salts and did not form isomers like their hydroxyl‐terminated counterparts. However, when the hydrochloride salts were free‐based before being incorporated into the formulations, they rapidly formed amides from the primary amine, acting as a nucleophile, resulting in a
mixture of methacrylates and methacrylamides (and likely hybrid methacrylate‐methacrylamide) monomers. Additional details are discussed in the supplementary information. Polymerization kinetics The reactivity rates as observed from the polymerization kinetics experiments ranked as follows: NH2‐ terminated methacrylates < OH‐terminated methacrylamides < OH‐terminated methacrylates. The NH2‐terminated methacrylates (AEMA, 1‐methyl AEMA and 2‐methyl AEMA) resulted in a copolymerization characterized by markedly low values of RPMAX and DC at RPMAX (Fig. 2 and Table 1). One possible explanation is potential phase‐separation, as the final polymer presented a nacre‐like structure. While one may expect the slow kinetics for these monomers would result in low final DC values, the final DCs were actually comparable or only slightly lower as compared to the other monomers. This was likely due to the long period of photoactivation which compensated for the slow curing kinetics. However, the low reactivity and phase‐separation make the NH2‐terminated monomers unsuitable for dental material compositions and, therefore were not subjected to further tests. For the remaining compounds, in general, OH‐terminated methacrylates showed higher values of RPMAX and DC at RPMAX than the secondary methacrylamides. This was expected since the tested methacrylates show lower molecular weight and viscosity than the methacrylamides, which likely increased the molecular mobility [Odian G. Principles of polymerization: John Wiley & Sons; 2004]. In addition, due to the known strong resonance stabilization of the carbonyl with the lone pair of electrons from the nitrogen, amide functionalities show significantly lower reactivity than methacrylates [Kovács et al., Molecules. 2018;23:2859]. The side‐group substitution played no significant role in the monomer reactivity, especially for the methacrylamides. It had previously been shown that the incorporation of ethyl or methyl side‐group substituents on the α carbon of secondary methacrylamides resulted in marginally increased polymerization reactivity and, subsequently, increased bonding performance [Fugolin et al., Dental Materials. 2019;35:686‐96]. An increase in polymerization kinetics of a methacrylamide monomer with side‐chain substitution can likely be attributed to amide twisting (a twisting of the amide C(O)–NH bond), which changes the geometry, reducing the contribution from the non‐propagating resonance form (Scheme 2 in supplemental materials) due to de‐conjugation of the nitrogen lone pair with the
carbonyl π‐system [Wang et al., Journal of the American Chemical Society. 1991;113:5757‐65]. In this study, the lack of an observable effect is likely due to the small steric profile of the methyl substitutions. The side‐group substitution played no significant role in the monomer reactivity, especially for the methacrylamides. It had previously been shown that the incorporation of ethyl or methyl side‐group substituents on the α carbon of secondary methacrylamides resulted in marginally increased polymerization reactivity and, subsequently, increased bonding performance [Fugolin et al., Dental Materials. 2019;35:686‐96]. An increase in polymerization kinetics of a methacrylamide monomer with side‐chain substitution can likely be attributed to amide twisting (a twisting of the amide C(O)–NH bond), which changes the geometry, reducing the contribution from the non‐propagating resonance form (Scheme 2 in supplemental materials) due to de‐conjugation of the nitrogen lone pair with the carbonyl π‐system [ Wang et al., Journal of the American Chemical Society. 1991;113:5757‐65]. In this study, the lack of an observable effect is likely due to the small steric profile of the methyl substitutions. The OH‐terminated methacrylate HEMA (control) presented the highest values of DC at RPMAX and final DC when polymerized at 50 °C, with HEMAM and 2‐methyl HEMAM being similar to each other. This was expected due to the differences in molecular weight, viscosity and reactivity among the compounds, as discussed above. The similarity of RPMAX among HEMA and the secondary methacrylamides was also observed for the polymerization kinetics evaluated at room temperature in this study and previously reported [Fugolin et al., Dental Materials. 2019;35:686‐96]. As mentioned above, HEMA has low molecular weight and viscosity (130 g/mol and 0.007 Pa.s), which increases the overall mobility within the comonomer system. This allows for a rapid increase in the rates of propagation and termination at the beginning of the polymerization reaction, until the formation of high molecular weight species severely hamper diffusion [Odian G. Principles of polymerization: John Wiley & Sons; 2004]. Despite methacrylates having higher reactivity than methacrylamides, the observed RPMAX values were similar. This observation reinforces that the methacrylamide‐methacrylate blend ratio used in this study provides good properties without a significant loss of polymerization reactivity. Another interesting finding is that the polymerization kinetics was less affected than expected when the polymerization was carried out at 50 °C, compared with room temperature. The increase in RPMAX was similar for HEMA and HEMAM (22% and 24%, respectively, and the DC at RPMAX increased by 19% for HEMA and 33% for HEMAM. The increase in and final DC was negligible. The effect on DC at RPMAX observed for HEMAM was expected based both on the increased mobility and on the decrease in activation energy at higher temperatures [Odian G. Principles of polymerization: John Wiley & Sons;
2004], mainly because of its greater hydrogen bonding potential and viscosity at room temperature [Daronch et al., Journal of Dental Research. 2005;84:663‐7], [Nie et al., Acta Polymerica. 1998;49:145‐61], [Bausch et al., Journal of Oral Rehabilitation. 1981;8:309‐17]. The absence of significant effects on final DC is likley due to the fact that the materials were polymerized at a relatively high intensity, for a relatively long time (300 s at 630 mW/cm2). Dentin microtensile bond strength The similarity of the μTBS (after 24 h) for commercial control Single Bond and the experimental secondary methacrylamides (HEMAM and 1‐methyl HEMAM formulations) suggests that the methacrylamides may be useful candidates as co‐monomers for improved dental adhesive formulations. The low μTBS of the HEMA α‐,β‐CH3 mix stands in contrast to the excellent polymerization kinetics observed. It is possible that the high polymerization rates and side‐group substitutions at the α‐
and β‐ carbons might have resulted in a poorly packed polymer network with compromised mechanical properties [Pfeifer et al., European Polymer Journal. 2011;47:162‐70]. The β‐substituted 2‐methyl HEMAM showed a statistically equivalent μTBS to the other secondary methacrylamides (HEMAM and 1‐methyl HEMAM), though lower than Single Bond. A previous study has shown that the performance of the (meth)acrylamide copolymers is highly dependent on the chemical structure localized about the amide, as well as the blending monomer [Fugolin et al., Dental Materials. 2019;35:686‐96]. As mentioned previously, 2‐methyl HEMAM is a powder and, even after the addition of solvent for the adhesive formulation, still led to a product with noticeably higher viscosity compared with the remaining monomers. Even though viscosity was not measured in this study, it can be speculated that this affected the quality of the hybridization of the collagen substrate in the 2‐methyl HEMAM group. At 6 months, while Single Bond, HEMAM and 1‐methyl HEMAM maintained the highest bond strengths, 2‐methyl HEMAM showed intermediate results, and the experimental methacrylates HEMA and HEMA α‐, β‐ CH3 mix the lowest bonds, which once again highlights the degradation resistance of the methacrylamides. Finally, the reduction in μTBS over time ranged between 37.5% for the methacrylate control, HEMA, and 5.7% for the α‐substituted secondary methacrylamide, 1‐methyl HEMAM, which can be explained by the increased resistance to hydrolysis of the methacrylamides compared to their methacrylate counterparts.
Monomer hydrolysis kinetics The hydrolysis results confirmed the expected increased resistance to hydrolysis, as all methacrylate monomers showed significantly more degradation in acidic aqueous conditions than the methacrylamide monomers. Notably, the hydrolysis rates of the amides vs esters were in agreement with simple chemical models which predict a factor of ten difference ([28], Scheme 1 in supplemental materials). The unsubstituted methacrylate, HEMA, and mixture of isomers, HEMA α‐,β‐CH3, performed similarly to each other and poorly in comparison to the methacrylamides in the degradation experiment. Both HEMA and HEMA α‐,β‐CH3 had a half‐life of 9.52 days (linear regression), while the worst performing methacrylamide, 1‐methyl HEMAM, had a half‐life of 27.7 days. The HEMA α‐,β‐CH3 mixture of isomers was mostly composed of the β‐substituted 2‐methyl HEMA (3:1), but this appeared to have no benefit or detriment to the stability to acid‐catalyzed hydrolysis compared to HEMA. The hydrolysis results confirmed the expected increased resistance to hydrolysis, as all methacrylate monomers showed significantly more degradation in acidic aqueous conditions than the methacrylamide monomers. Notably, the hydrolysis rates of the amides vs esters were in agreement with simple chemical models which predict a factor of ten difference ([Charton et al., Journal of Organic Chemistry. 1978;43:3995‐4001], Scheme 1 in supplemental materials). The unsubstituted methacrylate, HEMA, and mixture of isomers, HEMA α‐,β‐CH3, performed similarly to each other and poorly in comparison to the methacrylamides in the degradation experiment. Both HEMA and HEMA α‐,β‐CH3 had a half‐life of 9.52 days (linear regression), while the worst performing methacrylamide, 1‐methyl HEMAM, had a half‐life of 27.7 days. The HEMA α‐,β‐CH3 mixture of isomers was mostly composed of the β‐substituted 2‐methyl HEMA (3:1), but this appeared to have no benefit or detriment to the stability to acid‐catalyzed hydrolysis compared to HEMA. Interestingly, the addition of a α‐ or β‐CH3 groups had a detrimental effect (i.e., increased hydrolysis rate). The α‐,β‐CH3 methacrylamides (1‐methyl and 2‐methyl HEMAM) showed higher degradation rates (half‐lives of 68.8 and 27.7 days, respectively) compared to unsubstituted HEMAM (half‐life of 101 days). The α‐CH3 substituted 1‐methyl HEMAM was hydrolyzed about 3.5 times faster than HEMAM, with the the β‐CH3 substituted 2‐methyl HEMAM being hydrolyzed about 1.5 times faster than HEMAM. This trend is the opposite of what was expected from a simple chemical steric model for base‐assisted hydrolysis (Scheme 1 in supplemental materials). Notably, the magnitude of the effect is approximately the same. These observations suggest that for the acid catalyzed hydrolysis reaction, increased steric influence accelerates the leaving group (X‐R in Scheme 1 in supplemental materials).
This would be the case, for example, if protonation of the heteroatom (O for ester, NH for amide) were the rate‐limiting step instead of the H2O nucleophilic attack of the carbonyl, which also tracks with the basicity of the heteroatom increasing in the order (e.g., HEMAM < 1‐methyl HEMAM < 2‐methyl HEMAM). Interestingly, the addition of a α‐ or β‐CH3 groups had a detrimental effect (i.e., increased hydrolysis rate). The α‐,β‐CH3 methacrylamides (1‐methyl and 2‐methyl HEMAM) showed higher degradation rates (half‐lives of 68.8 and 27.7 days, respectively) compared to unsubstituted HEMAM (half‐life of 101 days). The α‐CH3 substituted 1‐methyl HEMAM was hydrolyzed about 3.5 times faster than HEMAM, with the the β‐CH3 substituted 2‐methyl HEMAM being hydrolyzed about 1.5 times faster than HEMAM. This trend is the opposite of what was expected from a simple chemical steric model for base‐assisted hydrolysis (Scheme 1 in supplemental materials). Notably, the magnitude of the effect is approximately the same. These observations suggest that for the acid catalyzed hydrolysis reaction, increased steric influence accelerates the leaving group (X‐R in Scheme 1 in supplemental materials). This would be the case, for example, if protonation of the heteroatom (O for ester, NH for amide) were the rate‐limiting step instead of the H2O nucleophilic attack of the carbonyl, which also tracks with the basicity of the heteroatom increasing in the order (e.g., HEMAM < 1‐methyl HEMAM < 2‐methyl HEMAM). During the hydrolysis experiment, transesterification products were observed for the methacrylamide monomers. Acid and base catalyzed transesterification of monomers like HEMA have been reported under concentrated conditions, such as hydrogels [Lee et al., Journal of Polymer Science, Part A: Polymer Chemistry. 2002;40:1858‐67]; however, this was an unexpected chemical equilibrium at the dilute aqueous conditions of the experiment. 1‐methyl HEMAM exhibited the most transesterification product after 17 days, making up 9.0%. While this number may seem small, only 34.6% of the monomer hydrolyzed at this time point meaning 26.0% of the 2‐aminopropan‐1‐ol degradation product re‐esterified into the methacrylate transesterification product, 2‐methyl AEMA. During the hydrolysis experiment, transesterification products were observed for the methacrylamide monomers. Acid and base catalyzed transesterification of monomers like HEMA have been reported under concentrated conditions, such as hydrogels [[Lee et al., Journal of Polymer Science, Part A: Polymer Chemistry. 2002;40:1858‐67]; however, this was an unexpected chemical equilibrium at the dilute aqueous conditions of the experiment. 1‐methyl HEMAM exhibited the most transesterification product after 17 days, making up 9.0%. While this number may seem small, only
34.6% of the monomer hydrolyzed at this time point meaning 26.0% of the 2‐aminopropan‐1‐ol degradation product re‐esterified into the methacrylate transesterification product, 2‐methyl AEMA. The re‐esterification likely occurred due to the low pH of the aqueous environment. At pH = 1, the amino group is more than 9 units below its pKa and the population of water molecules is essentially all hydronium ions, leaving the alcohol as the best available nucleophile for the transesterification reaction. This concept is consistent in the other methacrylamide groups, HEMAM and 2‐methyl HEMAM. In the case of HEMAM, there is very little monomer hydrolysis, only 10.9%, but 36.3% of the less sterically hindered degradation product, aminoethanol, re‐esterifies to form AEMA. Of the 16.51% of hydrolyzed 2‐methyl AEMA, only 22.8% re‐esterifies into the transesterification product, 1‐methyl AEMA. The re‐esterification likely occurred due to the low pH of the aqueous environment. At pH = 1, the amino group is more than 9 units below its pKa and the population of water molecules is essentially all hydronium ions, leaving the alcohol as the best available nucleophile for the transesterification reaction. This concept is consistent in the other methacrylamide groups, HEMAM and 2‐methyl HEMAM. In the case of HEMAM, there is very little monomer hydrolysis, only 10.9%, but 36.3% of the less sterically hindered degradation product, aminoethanol, re‐esterifies to form AEMA. Of the 16.51% of hydrolyzed 2‐methyl AEMA, only 22.8% re‐esterifies into the transesterification product, 1‐methyl AEMA (see Figs. 6 and 7). The secondary alcohol of the 1‐aminopropan‐2‐ol is less nucleophilic than the primary alcohol of 2‐aminopropan‐1‐ol and aminoethanol, resulting in less re‐esterification of the degradation products. The fact that weak nucleophiles such as secondary alcohols are able to participate in this transesterification suggests that the activated carbonyls of methacrylates and methacrylamides are very prone to transesterification. In the case of HEMA, much like in the discussion of amino‐terminated monomers, this transesterification can go unnoticed as ethylene glycol can only re‐esterify into HEMA. This would mean that the HEMA molecule is breaking and reforming, which makes the degradation of HEMA appear artificially slow compared to the methacrylamide groups where the amine is protonated and unable to participate in re‐esterification of the original monomer. More importantly, this evidence of transesterification would suggest that more care should be used when analyzing degradation products of dental materials as the degradation product mixtures have potential to be more complex than simply primary degradation products.
Conclusions The blend of methacrylamides (40 wt%) in methacrylates produced good bond strengths and excellent hydrolytic stability, while retaining acceptable polymerization kinetics. α‐and β‐CH3 derivatives had a non‐measurable effect on polymerization kinetics, suggesting that the methyl moiety is not sufficiently sterically hindering to affect the reactivity as previously seen with larger ethyl groups. NH2‐ terminated monomers had unacceptable polymerization rates, making these non‐starters for dental materials. Even the fast polymerization kinetics of HEMA α‐β‐CH3 mixture along with the side‐group substitutions compromised bond strength. Amide monomers were approximately ten times more stable to hydrolysis than the analogous methacrylates. The addition of a α
or β‐CH3 groups increased the rate of hydrolysis. The magnitude of the effect was approximately the same as a model system (base‐catalyzed hydrolysis of esters or amides) but opposite in influence. The α‐CH3 substituted secondary methacrylamide, 1‐methyl HEMAM, showed the most stable adhesive interface. Finally, a side reaction was observed with transesterification of the monomers studied under ambient conditions. Transesterifications of this nature typically occur under much harsher reaction conditions, and it is not clear why the transesterification of the diol moiety is so facile for methacrylates compared to simple esters. Scheme 1 below represents steric influence of side‐chain functionality on the relative rates of base catalyzed ester hydrolysis and amide hydrolysis (Charton 1978). Note that α‐Me substituents have a maximum effect of ~1.5‐1.8 times slower hydrolysis.
Scheme 2 below provides a) General reaction scheme for amide and ester polymerization and subsequent hydrolysis. b) Resonance structures for the radical polymerization intermediate showing propagating and non‐propagating resonance differences between esters and amides.
X = O minor resonance form X = NH major resonance form Scheme 3 below depicts 1‐methyl HEMA as an example of isomerization through transesterification of substituted hydroxyl‐terminated methacrylates towards thermodynamic equilibrium resulting in a mixture of isomers.
Figure 6 provides names and abbreviations of the evaluated monomers along with the associated transesterification and degradation products. Synthesis and characterization of 1‐methyl HEMAM
N‐(1‐hydroxypropan‐2‐yl)methacrylamide (1‐methyl HEMAM): Freshly distilled methacryloyl chloride (60.0 mmol, 1 equiv.) in anhydrous DCM (20 mL) was added dropwise to a stirred solution of 2‐ aminopropanol (63.0 mmol, 1.05 equiv.), trimethylamine (60.0 mmol, 1 equiv.) and 5 mg of 4‐ methoxyphenol in anhydrous DCM (30 mL) at ‐5 °C. The temperature was maintained after the addition for 2 hours before adding a catalytic amount of 4‐dimethylaminopyridine (3.0 mmol, 0.05 equiv.). The mixture was allowed to stir at room temperature for 36 before filtration. The organic filtrate was washed with 20 mL of 0.1 M NaOH solution and saturated brine. The organic layer was dried over Na2SO4, filtered, and concentrated under reduced pressure to give the crude product as a pale yellow oil. The crude product was purified using a Buchi Reveleris X2 flash chromatography system (mobile phase A was hexanes and mobile phase B (MPB) was EtOAc, with a gradient program of 11% MPB for 1 min, 11% MPB to 47% MPB over 14.3 min and hold at 47% for 7.2 min). The fractions were collected and concentrated under reduced pressure, yielding the final product as an off‐white solid (25.9 mmol, 43.2% yield). 1H NMR (400 MHz, Deuterium Oxide) δ 5.63 – 5.51 (m, 1H), 5.42 – 5.26 (m, 1H), 3.96 (h, J = 6.8 Hz, 1H), 3.53 (dd, J = 11.5, 4.9 Hz, 1H), 3.46 (dd, J = 11.4, 6.7 Hz, 1H), 1.84 (s, 3H), 1.07 (d, J = 6.8 Hz, 3H). 13C{1H} NMR (101 MHz, Chloroform‐d) δ 168.98, 139.79, 119.90, 66.24, 47.61, 18.59, 16.97. Synthesis and characterization of amine hydrochloride salt terminated monomers
1‐aminoprop‐2‐yl methacrylate hydrochloride (1‐methyl AEMA•HCl): 1‐aminopropan‐2‐ol (45.1 mmol) was added dropwise to stirring solution of conc. HCl (45.1 mmol) aqueous solution at 0 °C. The solution was stirred and temperature maintained for 20 minutes followed by distillation under reduced pressure at 60 °C to remove excess HCl. The remaining aqueous solution was lyophilized resulting in white solid hydrochloride salt. 4‐methoxyphenol (1.0 mol%) was added to the hydrochloride salt and heated to 85 °C. Methacryloyl chloride (54.1 mmol, 1.2 equiv) was added and stirred for 2 hours. A sweep of N2 gas was bubbled into a saturated sodium bicarbonate aqueous solution to trap the resulting HCl gas. After cooling to 40 °C, 12 mL of THF was added and the resulting solution was added dropwise to 100 mL of diethyl ether, precipitating a white solid (21.8 mmol, 48.3% yield). 1H NMR (400 MHz, Deuterium Oxide) δ 6.27 – 6.12 (m, 1H), 5.85 – 5.71 (m, 1H), 5.31 – 5.10 (m, 1H), 3.38 – 3.18 (m, 2H), 1.95 (s, 3H), 1.37 (d, J = 6.5 Hz, 3H).
2‐aminopropyl methacrylate hydrochloride (2‐methyl AEMA•HCl): 2‐aminopropan‐1‐ol (57.5 mmol) was added dropwise to stirring solution of conc. HCl (57.5 mmol) aqueous solution at 0 °C. The solution was stirred and temperature maintained for 20 minutes followed by distillation under reduced pressure at 60 °C to remove excess HCl. The remaining aqueous solution was lyophilized resulting in white solid hydrochloride salt. 4‐methoxyphenol (1.0 mol%) was added to the hydrochloride salt and heated to 85 °C. Methacryloyl chloride (69.0 mmol, 1.2 equiv) was added and stirred for 2 hours. A sweep of N2 gas was bubbled into a saturated sodium bicarbonate aqueous solution to trap the resulting HCl gas. After cooling to 40 °C, 15 mL of THF was added and the resulting solution was added dropwise to 100 mL of diethyl ether, precipitating a white solid (33.6 mmol, 58.4% yield). 1H NMR (400 MHz, Deuterium Oxide) δ 6.26 – 6.18 (m, 1H), 5.83 – 5.76 (m, 1H), 4.41 (dd, J = 12.3, 3.4 Hz, 1H), 4.26 (dd, J = 12.3, 7.0 Hz, 1H), 3.85 – 3.72 (m, 1H), 1.96 (s, 3H), 1.39 (d, J = 6.8 Hz, 3H). Neutralization of amine terminated monomers General Procedure: 2‐aminoethyl methacrylate hydrochloride salt (2‐AEMA•HCl; CAS# 2420‐94‐2) was obtained from Sigma Aldrich. 1‐aminoprop‐2‐yl methacrylate hydrochloride (1‐methyl AEMA•HCl) and 2‐ aminopropyl methacrylate hydrochloride (2‐methyl AEMA•HCl) were synthesized as described above. The hydrochloride salts (10.0 mmol) were neutralized by slurrying the solids in 25 mL dichloromethane (DCM) and an excess of triethylamine (15.0 mmol) for 1 hour. After filtration, the filtrate was concentrated under reduced pressure at 25 °C. Due to the limited solubility of TEA•HCl salt in DCM, some salts remained after removal of solvent. The oil was dissolved in 10 mL acetone, filtered, and concentrated to an oil under reduced pressure. All compounds were observed as slightly yellow oil and were stored under N2 gas until use in formulations. General Characterization Considerations: 1H NMR spectra of the resulting products in CDCl3. Upon neutralization, a transesterification resulting in a methacrylamide compound occurred in all cases. This transesterification can be observed by NMR spectroscopy: the vinyl proton peaks around 5.7 and 5.3 ppm (actual ppm vary for each compound) are upfield from the methacrylate vinyl proton peaks around 6.1
and 5.6 ppm. Additionally, there is a set of methacrylate vinyl proton peaks that are likely from the presence of methacrylic acid (presumably from the hydrolysis of the product compounds). Anhydrous TEA would be likely avoid methacrylic acid formation. Attempts to characterize the complex mixtures resulting from the neutralization of each compound can be found in the figures below. Further purification is needed for a complete characterization of the resulting mixture; however, this falls outside of the scope of this paper. Nonetheless, understanding the reaction paradigm can be established using the observational data as is. When 1‐methyl AEMA hydrochloride salt is neutralized, the resulting mixture of compounds is almost all (~93%) the transesterication product, 2‐methyl HEMAM, which has secondary alcohol. In contrast, when 2‐methyl AEMA hydrochloride salt is neutralized, the resulting mixture is more evenly distributed between the neutralized 2‐methyl AEMA, the transesterification product 1‐methyl HEMAM, and methacrylic acid. This difference could be explained by the difference in nucleophilicity of the pendant alcohol in the transesterification product, where 1‐methyl HEMAM has a primary alcohol and 2‐methyl HEMAM has a secondary alcohol. The primary alcohol of 1‐methyl HEMAM is able to participate in a transesterification reaction back to the intended compound 2‐methyl AEMA, pushing the equilibrium to lie between the intended product and the transesterification product. The alcohol of 2‐methyl HEMAM is much less nucleophilic as a secondary alcohol and would have a much slower re‐esterification reaction back to 1‐ methyl AEMA, resulting in an equilibrium with mostly transesterification product and very little 1‐methyl AEMA. Interestingly, the unsubstituted version, resulted in very little of the transesterification product HEMAM. This could possibly suggest that transesterification occurs through both an intermolecular mechanism and an intramolecular mechanism. The addition of steric bulk in the form of methyl substituents would be expected to favor intramolecular transesterification due to the Thorpe‐Ingold effect and could explain why there is more transesterification products in the 1‐methyl and 2‐methyl AEMA samples. Additional investigation into this product mixtures is needed to determine the presence of any other compounds important to better understanding the dynamics of the neutralization reaction, such as methacrylate‐methacrylamide hybrid monomers and oxazoline byproducts that could have formed. The instability of the amino‐terminated monomers in neutralized form prevents a clear understanding of the effects of methyl substituent placement as this cannot be observed in the complex mixture that forms after neutralization. Additionally, while the hydrochloride salt forms are stable and able to be purified, they cannot included in the systematic evaluation due to large changes in properties
(hydrophilicity, water absorption) that would occur from including a salt in formulation and due to the likely transesterification that would occur upon exposure to bases present in co‐monomers or initiators during formulation.
1‐methacrylamido‐2‐methylpropan‐2‐yl methacrylate (2dMM Hybrid): colorless oil. IR (neat) νmax 3341, 3086, 2978, 2959, 2927, 2849, 1720, 1664, 1626, 1528, 1477, 1455, 1405, 1393, 1367, 1321, 1298, 1251, 1166, 1021, 989, 940, 813 cm‐1. 1H NMR (400 MHz, Chloroform‐d) δ 6.10 – 6.03 (m, 1H), 6.03 – 5.95 (br, 1H), 5.60 – 5.48 (m, 2H), 5.27 – 5.17 (m, 1H), 4.22 (s, 2H), 1.91 – 1.87 (m, 3H), 1.88 – 1.83 (m, 3H), 1.37 (s, 6H). 13C NMR (101 MHz, Chloroform‐d) δ 168.15, 167.34, 140.90, 135.98, 125.93, 118.89, 69.59, 53.62, 23.79, 18.62, 18.24.
2‐methacrylamidobutyl methacrylate (2EM Hybrid): slight yellow oil. IR (neat) νmax 3319, 3806, 3050, 2968, 2930, 2879, 2740, 1721, 1656, 1620, 1532, 1456, 1404, 1377, 1323, 1297, 1206, 1169, 1042, 1013, 983, 939, 814, 784 cm‐1. 1
NMR (400 MHz, Chloroform‐d) δ 6.10 – 6.04 (m, 1H), 6.03 – 5.96 (m, 1H), 5.63 – 5.56 (br, 1H), 5.55 – 5.49 (m, 1H), 5.29 – 5.21 (m, 1H), 4.26 – 4.02 (m, 3H), 1.89 (s, 3H), 1.88 (s, 3H), 1.66 – 1.42 (m, 2H), 0.92 (t, J = 7.5 Hz, 3H). 13C NMR (101 MHz, Chloroform‐d) δ 168.30, 167.50, 140.18, 135.95, 126.07, 119.33, 65.73, 50.10, 24.67, 18.66, 18.29, 10.33.
2‐methacrylamidoethyl methacrylate (HEMAM Hybrid): yellow oil. IR (neat) νmax 3342, 3807, 2981, 2957, 2928, 2851, 1744, 1720, 1659, 1622, 1531, 1453, 1377, 1403, 1320, 1296, 1250, 1204, 1167, 1121, 1108, 1082, 1037, 1011, 941, 814 cm‐1. 1H NMR (400 MHz, DMSO‐d6) δ 8.16 – 7.95 (br, 1H), 6.24 – 5.96 (m, 1H), 5.92 – 5.65 (m, 1H), 5.65 – 5.60 (m, 1H), 5.39 – 5.27 (m, 1H), 4.13 (t, J = 5.8 Hz, 2H), 3.39 (q, J = 5.6 Hz, 2H), 1.94 – 1.85 (m, 3H), 1.84 (s, 3H). 13C NMR (101 MHz, DMSO‐d6) δ 168.22, 166.98, 140.30, 136.31, 126.28, 119.54, 63.23, 38.36, 19.04, 18.43. Materials and Methods Tested monomers and synthesis procedures The tested monomers are shown in Figure 1. All commercially‐available monomers were purchased from Sigma‐Aldrich (Milwaukee, WI, USA) at 97% purity and used as received. The chemical structure of the secondary methacrylamide N‐hydroxyethyl methacrylamide (HEMAM) was modified with ethyl and methyl substituents on the first (alpha) carbon (2EM and 2dMM, respectively), as described previously [Fugolin et al., Dental Materials. 2019;35:686‐96]. The hybrid versions of these monomers were isolated via chromatography, as described in the supporting information. NMR and IR spectral data can also be found in the supporting information. N‐hydroxyethyl methacrylate (HEMA) was tested as monofunctional methacrylate control. Triethyleneglycol dimethacrylate (TEGDMA) was tested as difunctional methacrylate control to provide a comparison with the difunctional methacrylamide‐methacrylate hybrid monomers. The partition coefficient (log P) for each monomer was calculated using the software package Chem Draw Ultra 14.1 (Perkin Elmer, San Jose, CA, USA). Tested formulations and photocuring conditions The monomers shown in Figure 1 were mixed at 40 mass% with bisphenol A‐glycidyl methacrylate (bisGMA). The photoinitiator system consisted of DMPA (2,2‐dimethoxy‐2‐phenylacetophenone, λmax=365 nm) and DPI‐PF6 (diphenyliodonium hexafluorophosphate) at 0.2 mass% and 0.4 mass%, respectively. Butylated hydroxytoluene (BHT) was added at 0.1 mass% to each formulation as a free‐radical inhibitor. For the dentin microtensile bond strength test only, experiments were conducted with fully formulated adhesives containing 40 vol% of ethanol to provide appropriate viscosity for proper dentin penetration and subsequent volatilization by air drying. All photocuring procedures were accomplished by a mercury arc lamp (Acticure 4000 UV Cure, Mississauga, Canada) filtered to 320–500 nm at 630 mW/cm2 measured directly at the sample surface using a thermopile power meter (Molectron PM100, Portland, OR, USA). The choice of light source was intended to match the initiator system used.
Kinetics of polymerization The kinetics of polymerization were assessed in near‐IR spectroscopy (Nicolet 6700, Thermo Scientific, USA) in real time during the photopolymerization of disc‐shaped samples (10 mm in diameter and 0.8 mm in thickness; measured with a digital caliper to 0.01 mm) for 300 seconds (n = 3). Each spectrum was collected with 2 scans at 4 cm‐1 resolution. This resolution allowed for baseline correction without compromising the sampling rate and signal‐to‐noise ratio. The final carbon‐carbon double bond conversion (final DC) was calculate based on the areas of the peaks (obtained with the processing tool in the OMNIC software) at 6165 and 6135 cm‐1, which correspond to the vinyl overtone for methacrylates and methacrylamides, respectively. The maximum rate of polymerization (RPMAX), representing the reactivity of the monomers, was determined as the first derivative of the degree of conversion as a function of the time. The degree of conversion at the maximum rate of polymerization (DC at RPMAX) was used to estimate the time point in conversion at which diffusional limitations lead to deceleration. Water sorption and solubility Water sorption (WS) and solubility (SL) were measured according to the ISO 4049:2019. Briefly, the same samples obtained in the polymerization kinetics test (n=3), after having their initial mass M1 determined, were immersed in 5 mL of triple distilled water for 7 days. At the end of this period, M2 was measured and the samples were stored in a desiccator containing silica gel and connected to the house vacuum. Sample weights were measured daily until the final mass did not change to the nearest 0.0001 g (M3). WS and SL were calculated in µg/mm3 according the following equations, where V is the volume of the disc in mm3:
Storage modulus in shear The storage modulus in shear (G’, n=5) was assessed in an oscillatory rheometer (Discovery HR‐1 Hybrid Rheometer, TA Instruments, New Castle, DE, USA), using an 8‐mm diameter aluminum plate attached to the upper fixture and an acrylic plate mounted to the UV‐Vis accessory on the bottom. Approximately 0.02 g of each material (the exact mass was recorded for each specimen and used to
calculate G’) was placed between the parallel plates, and the light was delivered through the acrylic via the optical apparatus in the UV‐Vis accessory. Samples were tested in oscillation mode (sine wave) at 10 Hz and 0.1% strain with a gap of 0.3 mm during the photopolymerization for 300 s (n = 3). Dentin microtensile bond strength Selected formulations with the highest G’ and lowest WS and SL were subjected to dentin microtensile bond strength testing (µTBS). Sound human dentin of extracted caries‐free third molars was used as the substrate. The study was approved by the Oregon Health & Science University IRB (IRB00012056). The enamel was removed and the resulting surface was roughened by hand with light pressure and one pass across wet #600 silicon carbide paper to simulate smear layer formation. The dentin surface was etched for 15 s with 37% phosphoric acid (3M ESPE), rinsed and dried with the aid of gentle air stream for about 10 s. Two layers of the adhesive were applied and, after solvent evaporation, the second layer was photocured for 60 s at 630 mW/cm2 by the mercury arc lamp. Restorative procedures consisted of a block of Filtek Supreme (shade A2 ‐ 3M ESPE) built in 2 increments of 2 mm each, photoactived with the light guide directly over the surface for 20 s at 1200 mW/cm2 with an EliparTM DeepCure‐S LED (3M ESPE). Adper Single Bond (3M ESPE) was tested as a commercial adhesive control, in two consecutive layers, air‐dried to remove excess solvent, and photoactivated for 20 s using the same light curing unit settings (n=6). 24 hours after the restorative procedures, teeth were sectioned under water in a slow speed diamond saw (Accutom‐50, Struers) to obtain sticks of 1 mm2 cross‐sectional area (checked with a digital caliper to 0.01 mm). The sticks were tested after 24 h or 6 months water storage at 37 °C. Sticks were glued with cyanoacrylate (Zap‐it, Dental Ventures of America, Corona, CA, USA) onto custom‐made jigs (Odeme Equipment, Luzerna, SC, Brazil) attached to a universal testing machine (Criterion MTS, Eden Prairie, MN, USA) and tested in tension until failure (0.5 mm/min). Statistical Analysis Data was statistically analysed by one‐way ANOVA and Tukey’s test (α = 0.05), after assessment of normality and homoscedasticity. For µTBS, Student’s t‐test was carried out to compare the effect of the storage time (α = 0.05). In the instances where the normality tests failed, the nonparametric Kruskal‐ Wallis test was carried out (α = 0.05). Results
Kinetics of polymerization curves (average of three curves) are depicted in Figure 2 and results shown in Table 1. RPMAX ranged between 0.11 and 0.03 %.s‐1, with TEGDMA and HEMAM Hy showing the highest and lowest values, respectively. The other groups were statistically similar (Table 1). A similar trend was found for the DC at RPMAX results, which ranged between 21.0 and 8.7%, with the methacrylates TEGDMA and HEMA showing the highest values and HEMAM Hy the lowest. In terms of final DC, the monofunctional HEMA and HEMAM showed the highest values (89.0 and 83.2%, respectively) and the hybrid versions HEMAM Hy, 2EM Hy and 2dMM Hy the lowest (63.5, 63.3, and 59.4%, respectively). In general, the alpha‐substituted methacrylamides 2EM and 2dMM showed lower values than the monofunctional methacrylate control HEMA (73.6, 76.7 and 89.0%, respectively). Regarding water sorption and solubility (Figure 7), the WS values ranged between 33.4±3.2 and 183.0±5.7 µg/mm3 with the highest value being for the methacrylamide HEMAM, followed by 2EM, HEMA and 2dMM (101.3±1.5, 93.9±4.8, and 79.1±0.9 µg/mm3, respectively). TEGDMA and the hybrids were similar (35.5±1.8, 38.7±1.8, 44.0±0.8, and 33.4±3.2 µg/mm3, respectively). In terms of SL, the results ranged between ‐12.7±1.6 and 6.4±2.2 µg/mm3 for HEMA and 2EM/2dMM, respectively. The hybrids HEMAM Hy, 2EM Hy and 2dMM Hy were statistically similar to TEGDMA (‐1.6±0.0, 0.0±0.0, ‐0.5±2.4, and ‐4.2±6.0 µg/mm3, respectively). The shear storage modulus, G’, values ranged between 160.7±8.0 and 115.7±7.0 MPa for the hybrids HEMAM Hy and 2dMM Hy, respectively (Figure 4). In general, the groups were statistically similar and significant difference was only observed between HEMAM Hy versus TEGDMA, 2EM and 2dMM Hy. Dentin µTBS results are shown in Figure 5. Single Bond showed statistically higher values at both 48 h and 6 months (53.4±9.8 and 43.3±5.3 MPa, respectively), while all other groups were statistically similar to each other (ranging between 42.3±9.6 and 27.9±6.0 MPa and between 32.7±3.3 and 19.2±4.5 MPa for 48h and 6 months storage time, respectively). The µTBS decreased for all materials between 48 h and 6 months, and this reduction was statistically significant for the HEMA and two 2dMM compounds. The formulation containing the monofunctional methacrylamide (HEMAM) showed the lowest bond strength reduction (about 9%) after 6 months of aging, while the other groups showed a decrease ranging between 18 and 33%. Discussion The limited clinical durability reported for current esthetic, direct dental resin composite materials highlights the need for the development of alternative monomers to replace the widely‐used methacrylates which, despite the high reactivity and reasonable mechanical properties, are highly
susceptible to hydrolytic and enzymatic degradation due to the presence of ester bonds [Finer et al., Journal of Dental Research. 2004;83:22‐6; Finer et al., Biomaterials. 2004;25:1787‐93; and Kermanshahi et al., Journal of dental research. 2010;89:996‐1001]. Experimental dental adhesive formulations containing methacrylamides have shown significant long term dentin bonding stability, in spite of their lower reactivity, and of the high hydrophilicity that resulted in reduced values of certain mechanical properties [Fugolin et al., Dental Materials. 2019;35:686‐96; and Rodrigues et al., Dental Materials. 2018;34:1634‐44]. In an attempt to improve the reactivity of the amides and control their water sorption, in this study hybrid methacrylamide‐methacrylate difunctional monomers were designed, synthesized and tested as alternative co‐monomers for HEMA‐free dental adhesive formulations. The results showed that except for HEMAM Hy, all hybrid versions showed reactivity (RPMAX) similar to the methacrylate controls (TEGDMA and HEMA). HEMAM was expected to present the highest reactivity due to the absence of bulky substituents. The absence of substituents, in theory, would facilitate the access of the amine radicals to the vinyl groups. Albeit not statistically significant, the opposite was actually observed: the non‐substituted HEMAM showed 45% lower RPMAX than the alpha‐substituted versions. Steric interactions of substituents near amide bonds have been shown to cause slight rotation about the amide C‐N bond [Wang et al., Journal of the American Chemical Society. 1991;113:5757‐65], reducing the ability of the nitrogen atom to donate electrons into the conjugated system. This distortion of the amide bond results in a longer amide C‐N bond with less double bond character [Wang et al., Journal of the American Chemical Society. 1991;113:5757‐65]. Compared with the non‐substituted HEMAM, the distorted amides of the 2EM and 2dMM versions are not able to stabilize a radical as effectively, which could increase the rate of polymerization (Figure 6). Figure 6 depicts steric interactions of α‐carbon alkyl substituents have been shown to cause 2° and 3° amides to twist about the C‐N bond. The resulting “distorted” amides have less pi‐orbital overlap resulting in lengthened C‐N bonds and less electron donation of the lone pair into the conjugated system of the amide [16]. In the context of this work, the reduced electron donation and resulting reduction in radical stabilization is being used as a possible explanation for the reduced reactivity and rate of polymerization between non‐substituted monomers and monomers with one or more α‐carbon substituents. One additional explanation is based on the electron‐donating nature of the alkyl chains, which may have created a partial negative charge on the alpha‐carbon in 2EM and 2dMM [Bruice PY. Essential organic chemistry2016]. Combined with the negative partial charge inherent in the amide bond, this might have led to a spatial separation from the electron‐rich vinyl group and, ultimately, exposed the double
bond to free radical propagation. In short, the attachment of a second vinyl functionality to a sterically‐ hindered chemical structure made the resultant hybrid compound (HEMAM Hy) even less reactive. In general, all hybrid versions showed numerically or statistically (or both) lower RPMAX, DC at RPMAX and Final DC than their OH‐bearing versions. This was expected, since the reaction involves co‐ polymerizations between difunctional and monofunctional monomers, each with distinct individual reactivities. Expectations were that autoacceleration and autodeceleration would be impacted, ultimately leading to structural heterogeneity, unequal functional group reactivity and a delay in volumetric shrinkage rate [Anseth et al., Chemical Engineering Science. 1994;49:2207‐17]. The decrease in reactivity in systems containing high ratios of multifunctional molecules is related to polymer crosslinking, which impairs macro‐radical diffusion in the reaction environment. Since the mobility of the reactive species is hindered, both the termination and propagation kinetic constants decrease, which explains the lower rates of polymerization. In addition, the propagation becomes diffusion‐controlled earlier in the conversion in systems with higher ratios of difunctional monomers, as evidenced by the lower DC at RPMAX results. At RPMAX, diffusional limitations reach a threshold beyond which the reaction starts to decelerate, until the network completely vitrifies. DC at RPMAX results demonstrated that HEMAM Hy showed the lowest conversion at that point, which indicates its network vitrified much sooner in conversion. One additional factor to be considered is the unequal functional‐group reactivity in difunctional monomers. It has been demonstrated that, on average, only one unit of double bonds reacts per monomer independent of the number of functionalities (from one to five ‐ [Anseth et al., Chemical Engineering Science. 1994;49:2207‐17]. As one of the functional groups reacts and forms a covalent bond with a growing chain and/or another molecule, a congestion by the physical presence of surrounding ligands is created, which slows down or even prevents reaction at the second functional group [Anseth et al., Chemical Engineering Science. 1994;49:2207‐17]. In molecules with short and rigid carbon chains, such as the hybrids tested in the present study, this congestion is even stronger due to the close proximity of the functionalities and the hindrance to molecular stretching or rotation. The presence of aliphatic side chains in some of the molecules compound the steric hindrance effects. Furthermore, for the hybrid monomers, the process is further complicated by the inherent unequal reactivity between methacrylates and methacrylamides. The methacrylamides are markedly less reactive than the methacrylates due to the strong resonance stabilization of the vinyl group provided by the nitrogen atom [Miyake et al., Macromolecules. 2009;42:1462‐71]. In other words, despite having the same number of mesomeric structures, the amide functionality is more stabilized than the ester due to the fact that the nitrogen atom is less electronegative than the oxygen and, consequently, is a better donor of nonbonding electrons
[Kucharski et al., Journal of Applied Polymer Science. 1997;64:1259‐65]. Therefore, it can be postulated that the more reactive methacrylate reacted first, further decreasing the reactivity of the already stable methacrylamide functionality. Even though this falls outside the scope of this study, one future strategy to balance this uneven reactivity between the methacrylate and methacrylamide could be to vary the extender chain length, which could be tailored to modulate molecular degree of freedom, and therefore, make the methacrylamide vinyls more readily available to react [Ogliari et al., Dent Mater. 2008;24:165‐ 71]. Interestingly, in the kinetics curves profiles of HEMA, HEMAM and HEMAM Hy, two distinct slopes are noticed (Figure 9), which may indicate the presence of two phases with different compositions as the polymerization reactions take place at different rates [Pfeifer et al., Journal of Polymer Science Part A: Polymer Chemistry. 2014;52:1796‐806]. The decrease in viscosity promoted by the incorporation of HEMA, HEMAM and HEMAM Hy into the formulations may increase the mobility of the system, which may have caused the polymerization of the more reactive bisGMA to take place more or less independently, at a faster rate and with earlier vitrification compared with the other co‐monomers [[Pfeifer et al., Journal of Polymer Science Part A: Polymer Chemistry. 2014;52:1796‐806]. On the other hand, the polymerization of the diluent‐rich phase is hypothesized to have taken place at a slower rate, with delayed gelation and vitrification. It has been shown that during the co‐polymerization between methacrylates and methacrylamides, a radical is easily formed from a methacrylate molecule and it more likely reacts with a like monomer [Anseth et al., Chemical Engineering Science. 1994; 49:2207‐17]. Conversely, the amide radical has been shown to more likely react with the more reactive methacrylate rather than with another lower reactivity methacrylamide molecule, thereby enriching the co‐polymer with methacrylate units in comparison with the initial comonomer ratio [Kucharski et al., Journal of Applied Polymer Science. 1997;64:1259‐65]. In short, this differential reactivity may have led to the formation of interpenetrating polymer networks (IPNs) [Dean et al., Polymer International. 2004;53:1305‐ 13]. The lowest reactivities of HEMAM and especially HEMAM Hy are consistent with the possibility of IPN formation. It is interesting to note that the conversion at which the kinetic curve enters the deceleration phase shifts to earlier stages as the monomer reactivity decreases, which indicates a reduction in diffusivity of both polymer and monomer species [Anseth et al., Chemical Engineering Science. 1994; 49:2207‐17]. Finally, the non‐substituted HEMAM showed statistically higher final degree of conversion than the alpha‐substituted versions 2dMM and 2EM. The increase in final double bond conversion showed by HEMAM may be associated with the relative lower viscosity of this compound, which likely played a
role in preserving sufficient mobility in the system up to much higher levels in conversion [Odian G. Principles of polymerization: John Wiley & Sons; 2004]. Methacrylamides have hydrogen‐bond acceptor (O‐H dipole) and hydrogen‐bond donor (N‐H dipole) capabilities, which favors their interaction with water [DeRuiter et al., Principles of Drug Action. 2005;1:1‐16]. Therefore, one additional reason for the incorporation of the methacrylate functionality on the secondary methacrylamides was to reduce the latter’s hydrophilicity. The methacrylate‐ methacrylamide hybrids (HEMAM Hy, 2EM Hy, and 2dMM Hy) showed dramatic reduction in water sorption in comparison to their methacrylamide versions (HEMAM, 2EM, and 2dMM) (Figure 7), with methacrylate hybrids showing 3 to 6‐fold greater log P values. This means they are a lot more hydrophobic than the methacrylamide analogs. Molecular weight (MW), partition coefficient (log P) and percentage of carbon double bonds from methacrylamide and methacrylate functional groups (% [C=C]), and final degree of conversion (Final C=C) of the tested co‐monomers.
Several factors contribute to this increased hydrophobic character: increase in molecular weight, substitution of the hydrophilic hydroxyl group and addition of an aliphatic side radical, which all decrease the molecule polarity [Bruice PY. Essential organic chemistry2016]. The positive results of SL shown by the alpha‐substituted methacrylamides (2EM and 2dMM) indicate a higher degree of mass loss due to leaching out of unreacted monomers – the final degree of conversion was 75% on average. Regarding the mechanical properties, it was expected that the incorporation of difunctional molecules into the formulations would enhance the crosslinking and, ultimately, the shear modulus and
µTBS. However, no clear trend was identified in the shear storage modulus results among the difunctional molecules. HEMAM Hy showed the highest values and 2dMM Hy and TEGDMA the lowest ones, which indicates that the molecular packing and the intermolecular interactions are playing key roles. It is known for co‐polymerizations between TEGDMA and bisGMA that heterogeneous and poorly‐packed polymer networks result, due to TEGDMA’s tendency to cyclization, as well as bisGMA’s rigidity [Pfeifer et al., Eur Polym J. 2011;47:162‐70]. Cyclization is likely in difunctional molecules with flexible backbones, ultimately leading to the formation of a network with reduced cross‐linking density and glass transition temperature, despite the high levels of final degree of conversion [Anhseth et al., Chemical Engineering Science. 1994;49:2207‐17; Elliot et al., Dental Materials. 2001;17:221‐9; and Boots et al., Polymer Bulletin. 1984;11:415‐20]. In addition, the flexibility of the pendant groups and crosslinks make the TEGDMA molecule susceptible to rotational motion and with tendency to occupy more space, which compromises the packing efficiency and increases the free volume [Pfeifer et al., Eur Polym J. 2011;47:162‐70]. And finally, at the relatively high irradiances used in this study, the polymerization reaction takes place at higher rates (as evidenced by the RPMAX results), leading to the formation of a stiff framework with greater free volume [Pfeifer et al., Eur Polym J. 2011;47:162‐70]. In the case of 2dMM Hy, the presence of two bulky methyl substituent groups (each with three terminal hydrogens), jeopardizes the molecular packing arrangement. The combination with the second functionality on the rigid backbone makes 2dMM Hy a bulkier and highly sterically hindered molecule, which may have compromised not only the reactivity but also the polymer network structure. Conversely, the structure of HEMAM Hy does not contain any substituents, and its polymerization reaction took place at slow rates which, in tandem with the potential phase separation indicated by the double‐staged kinetic profile, may have led to toughening of the material, as previously demonstrated [Naficy et al., Journal of Applied Polymer Science. 2013;130:2504‐ 13]. On a related note, bars were prepared for dynamic mechanical analysis test, but the experiment was not conducted because, after the post‐curing heat processing necessary prior to the DMA test (16 hours at 180°C), the bars of HEMAM Hy, 2EM and 2dMM groups became too brittle and showed evidence of significant internal cracking (Figure 8). Though it is not completely clear why this happened for these specific groups, it can be speculated that the aforementioned molecular packing characteristics may have drastically reduced the toughness of the materials, which caused them to break upon thermal contraction. And finally, in respect to the µTBS results, SB showed statistically higher values at both 48 h and 6 months, while all other groups were statistically similar to each other. The μTBS decreased for all materials between 48 h and 6 months, and this reduction was significant for the HEMA and two 2dMM compositions. The formulation containing the monofunctional methacrylamide (HEMAM) showed the
lowest bond strength reduction (about 9%) after 6 months of aging, while the other groups showed a decrease ranging between 18 and 33%. The bonding stability of some of these methacrylamides is surprising given their high WS, reduced conversion and mechanical properties compared with the HEMA control. These results follow the same trend reported previously, and it points to the complexity of dentin bonding, which is not directly related to the monomer’s properties [Fugolin et al., Dental Materials. 2019;35:686‐96]. Interestingly, the interaction between the methacrylamides and the dentin substrate was chemical‐structure dependent, which makes it difficult to draw general conclusions. Studies have shown that the amides are able to establish hydrogen bonds with specific sites of the collagen, which may have contributed to some form of substrate reinforcement [Tatiana et al., Colloid and Polymer Science. 2018;296:1555‐71]. The hybrid strategy resulted in molecules with markedly lower water sorption. The potential increase in reactivity was overshadowed by electronic and steric factors on the tested monomers. Even though the microtensile bond strength was not improved in relation to the control, the stability of the bond observed with selected groups is an encouraging result. This description of embodiments is non‐limiting and provided as examples of combinations of elements that are supported herein. Additional combinations of elements are also understood to be within the scope of this disclosure. Additional non‐limiting exemplary embodiments for the subject matter disclosed herein are provided below. Embodiment 1 provides a dental adhesive composition comprising one or more monomer compounds selected from the group of:
. Embodiment 2 provides a dental adhesive composition comprising one or more monomer compounds selected from the group of:
Embodiment 3 provides a dental adhesive composition comprising one or more monomer compounds selected from the group of:
Embodiment 4 provides a dental adhesive composition comprising one or more monomer compounds selected from the group of:
Embodiment 5 provides a dental adhesive composition comprising one or more monomer compounds selected from the group of:
. Each of separate Embodiments 6 through 20 provides a dental adhesive composition comprising the monomer compound as identified for the individual embodiments by number below:
(
Embodiment 21 comprises the dental adhesive composition of any of Embodiments 1 through 20, further comprising a co‐monomer compound selected from the group of bisphenol A diglycidyl ether dimethacrylate (BisGMA), triethylene glycol dimethacrylate (TEGDMA), urethane dimethacrylate (UDMA), ethylene glycol dimethylacrylate (EGDMA), ethane‐1,2‐diyl bis(2‐methylacrylate) (PEGDMA), ethoxylated bisphenol A dimethacrylate (EBPADMA), ethylene glycoldi(meth)acrylate, hexanediol di(meth)acrylate, tripropylene glycol di(meth)acrylate, butanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, dipropylene glycol di(meth)acrylate, allyl (meth)acrylate, 1,6‐hexanediol dimethacrylate (HEDMA), 1,6‐ hexamethylene glycol dimethacrylate (HGDMA), and divinyl benzene, or derivatives thereof. Embodiment 22 comprises the dental adhesive composition of Embodiment 21, wherein the co‐ monomer compound is BisGMA. Embodiment 23 comprises the dental adhesive composition of Embodiment 21, wherein the co‐ monomer compound is TEGDMA. Embodiment 24 comprises the dental adhesive composition of Embodiment 21, wherein the co‐ monomer compound is UDMA. Embodiment 25 comprises the dental adhesive composition of Embodiment 21, wherein the co‐ monomer compound is EGDMA. Embodiment 26 comprises the dental adhesive composition of Embodiment 21, wherein the co‐ monomer compound is PEGDMA. Embodiment 27 comprises the dental adhesive composition of any of Embodiments 21 through 26, wherein: a) the relevant one or more monomers indicated in Embodiments 1 through 20 comprise from about 35% to about 45%, by weight, of the dental adhesive composition; and
b) the relevant co‐monomer compound indicated in Embodiments 21 through 26 comprises from about 55% to about 65%, by weight, of the composition. Embodiment 28 comprises the dental adhesive composition of any of Embodiments 21 through 26, wherein: a) the relevant one or more monomers indicated in Embodiments 1 through 20 comprise from about 37% to about 43%, by weight, of the dental adhesive composition; and b) the relevant co‐monomer compound indicated in Embodiments 21 through 26 comprises from about 57% to about 63%, by weight, of the composition. Embodiment 29 comprises the dental adhesive composition of any of Embodiments 1 through 28, wherein the dental adhesive composition further comprises a photoinitiator. Embodiment 30 comprises the dental adhesive composition of Embodiments 29, wherein the photoinitiator or polymerization initiator is selected from the group of camphorquinone (CQ); trimethylbenzoyl‐diphenyl‐phosphine oxide (TPO); Ethyl‐4‐dimethylamino benzoate (EDMAB); 2,2‐ Dimethoxy‐2‐phenylacetophenone (DMPA); Bisacylphosphine oxide (BAPO); 1‐Phenyl‐1,2‐propanedione (PPD); phosphine oxide compounds, including naphthacene (APO), 9‐anthracene (APO), and; 1‐phenyl‐ 1,2‐propanedione (PPD); thioxanthone (TX) and its derivatives; dibenzoyl germanium derivatives, such as benzoyltrimethylgermane (BTG) and dibenzoyldiethylgermane; hexaarylbiimidazole derivatives; silane based derivatives; (diethylgermanediyl)bis((4‐methoxyphenyl)methanone) (Ivocerin); benzenesulfinic acid sodium salt (BS); diaryliodonium salts (such as diphenyliodonium chloride or iodonium salt [diphenyliodonium hexafluorophosphate (DPIHP or DPI‐PF6 ))], or a bromide, iodide, or hexafluorophosphate thereof; lithium phenyl‐2,4,6‐trimethylbenzoylphosphinate; 2‐hydroxy‐1‐[4‐(2‐ hydroxyethyl)phenyl]‐2‐methyl‐1‐propanone (Irgacure 2959); and benzoyl peroxide (BPO). Embodiment 31 comprises the dental adhesive composition of any of Embodiments 29 and 30, wherein the photoinitiator or polymerization initiator is selected from the group of 2,2‐Dimethoxy‐2‐ phenylacetophenone (DMPA), diphenyliodonium hexafluorophosphate, and (diethylgermanediyl)bis((4‐ methoxyphenyl)methanone) (Ivocerin), or a combination thereof. Embodiment 32 comprises the dental adhesive composition of any of Embodiments 29, 30, and 31, wherein the photoinitiator or polymerization initiator is selected from the group of 2,2‐Dimethoxy‐2‐ phenylacetophenone (DMPA) and diphenyliodonium hexafluorophosphate, or a combination thereof.
Embodiment 33 comprises the dental adhesive composition of any of Embodiments 29, 30, 31, and 32, wherein the composition further comprises a chemical inhibitor/stabilizer/free radical scavenger selected from the group of butylated hydroxytoluene (BHT), hydroquinone, 2,5‐di‐tert‐butyl hydroquinone, monomethyl ether hydroquinone (MEHQ), and 2,5‐di‐tertiary butyl‐4‐methylphenol, 3,5‐ di‐tert‐butyl‐4‐hydroxyanisole (2,6‐di‐tert‐butyl‐4‐ethoxyphenol), 2,6‐di‐tert‐butyl‐4‐ (dimethylamino)methylphenol or 2‐(2′‐hydroxy‐5′‐methylphenyl)‐2H‐benzotriazole, 2‐(2′‐hydroxy‐5′‐t‐ octylphenyl)‐2H‐benzotriazole, 2‐(2′‐hydroxy‐4′,6′‐di‐tert‐pentylphenyl)‐2H‐benzotriazole, 2‐hydroxy‐4‐ n‐octoxybenzophenone, 2‐(2′‐hydroxy‐5′‐methacryloxy‐ethylphenyl)‐2H‐benzotriazole, phenothiazine, and HALS (hindered amine light stabilizers). Embodiment 34 comprises the dental adhesive composition of Embodiment 33, wherein the composition comprises a chemical inhibitor/stabilizer/free radical scavenger at a concentration of from about 0.01% to about 0.5%, by weight. Embodiment 35 comprises the dental adhesive composition of any of Embodiments 33 and 34, wherein the composition comprises a chemical inhibitor/stabilizer/free radical scavenger at a concentration of from about 0.05% to about 0.3%, by weight. Embodiment 36 comprises the dental adhesive composition of any of Embodiments 33, 34, and 35, wherein the composition comprises a chemical inhibitor/stabilizer/free radical scavenger at a concentration of from about 0.05% to about 0.2%, by weight. Embodiment 37 comprises the dental adhesive composition of any of Embodiments 33, 34, 35, and 36, wherein the composition comprises a chemical inhibitor/stabilizer/free radical scavenger is butylated hydroxytoluene (BHT). Embodiment 38 comprises the dental adhesive composition of any of Embodiments 1 through 37, wherein the dental adhesive composition further comprises a self‐etching agent. Embodiment 39 comprises the dental adhesive composition of Embodiment 38, wherein the self‐etching agent comprises a carboxylic acid, phosphonic acid, or phosphate groups Embodiment 40 comprises the dental adhesive agent of any of Embodiments 38 and 39, wherein the self‐etching agent is selected from the group of 10‐methacryloyloxydecyl dihydrogen phosphate (10‐MDP or MDP, CAS Reg. No. 85590‐007), methacryloxyethyl hydrogen phenyl phosphate (Phenyl-P), methacryloyloxydodecylpyridinium bromide (MDPB), 4‐methacryloyloxyethyl
trimellitate anhydride (4‐META), 4‐methacryloyloxyethyl trimellitic acid (4‐MET), 11‐methacryloyloxy‐ 1,1‐undecanedicarboxylic acid (MAC10), 4‐acryloyloxyethyl trimellitate anhydride (4‐AETA), 2‐ methacryloyloxyethyl dihydrogen phosphate (MEP), dipentaerithritol pentaacrylate phosphate (PENTA‐ P), hydroxyethylmethacrylate phosphate (HEMA‐P), hydroxyethylacrylate phosphate (HEA‐P), bis(HEMA)‐P {bis(hydroxyethylmethacrylate) phosphate), bis(HEA)‐P {bis(hydroxyethylacrylate) phosphate), bis(meth)acryloxypropyl)phosphatephosphate methacrylates, acrylic ether phosphonic acid and other phosphoric acid esters. Embodiment 40 provides a kit, the kit comprising a useful amount of a dental adhesive composition selected from any of Embodiments 1 through 39, and directions for the use of the adhesive dental composition.
Claims
2. The dental adhesive composition of Claim 1, further comprising a co-monomer compound selected from the group of bisphenol A diglycidyl ether dimethacrylate (BisGMA), triethylene glycol dimethacrylate (TEGDMA), urethane dimethacrylate (UDMA), ethylene glycol dimethylacrylate (EGDMA), ethane-1, 2-diyl bis(2-methylacrylate) (PEGDMA), ethoxylated bisphenol A dimethacrylate (EBPADMA), ethylene glycoldi(meth)acrylate, hexanediol di(meth)acrylate, tripropylene glycol di(meth)acrylate, butanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, diethylene
glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, dipropylene glycol di(meth)acrylate, allyl
(meth)acrylate, 1,6-hexanediol dimethacrylate (HEDMA), 1,6-hexamethylene glycol dimethacrylate
(HGDMA), and divinyl benzene.
3. The dental adhesive composition of Claim 2, wherein the co-monomer compound is selected from the group of BisGMA, TEGDMA, UDMA, EGDMA, and PEGDMA.
4. The dental adhesive composition of claim 3, wherein: a) the one or more compounds selected from the group of Claim 1 comprise from about
35% to about 45%, by weight, of the dental adhesive composition; and b) the co-monomer compound selected from the group of BisGMA, TEGDMA, UDMA,
EGDMA, and PEGDMA comprises from about 55% to about 65%, by weight, of the composition.
5. The composition of Claim 4 further comprising a photoinitiator.
6. The composition of Claim 5 comprising from about 0.1 to about 0.3% by weight DMPA.
7. The composition of Claim 5 comprising from about 0.2% to about 0.6% DPI-PF6.
8. The composition of Claim 5 comprising from about 0.1 to about 0.3% by weight DMPA and from about 0.2% to about 0.6% DPI-PF6.
10. The composition of Claim 9 further comprising a photoinitiator.
12. The composition of Claim 11 further comprising a photoinitiator.
; and b) from about 55% to about 65%, by weight, a co-monomer compound selected from the group of BisGMA, TEGDMA, UDMA, EGDMA, and PEGDMA.
14. The composition of Claim 13 further comprising a photoinitiator.
15. The dental adhesive composition of Claim 4 comprising: a) from about 35% to about 45% by weight a compound selected from the group of:
16. The dental adhesive composition of Claim 15 further comprising a photoinitiator.
17. The dental adhesive composition of Claim 16, wherein the photoinitiator is one or more agents selected from the group of DMPA and DPI-PF6.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163152241P | 2021-02-22 | 2021-02-22 | |
US63/152,241 | 2021-02-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022178444A1 true WO2022178444A1 (en) | 2022-08-25 |
Family
ID=82931836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2022/017365 WO2022178444A1 (en) | 2021-02-22 | 2022-02-22 | Dental adhesives formulated with secondary methacrylamides |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022178444A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140329929A1 (en) * | 2011-09-08 | 2014-11-06 | Ivoclar Vivadent Ag | Dental materials based on monomers having debonding-on-demand properties |
BR102018013012A2 (en) * | 2018-06-25 | 2020-01-07 | Sociedade Unificada Paulista De Ensino Renovado Objetivo - Supero Ltda. | DENTAL ADHESIVE HIGH REACTIVITY RESTAURANT |
US20210047450A1 (en) * | 2018-03-08 | 2021-02-18 | Oregon Health & Science University | Methacrylamide adhesive systems |
-
2022
- 2022-02-22 WO PCT/US2022/017365 patent/WO2022178444A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140329929A1 (en) * | 2011-09-08 | 2014-11-06 | Ivoclar Vivadent Ag | Dental materials based on monomers having debonding-on-demand properties |
US20210047450A1 (en) * | 2018-03-08 | 2021-02-18 | Oregon Health & Science University | Methacrylamide adhesive systems |
BR102018013012A2 (en) * | 2018-06-25 | 2020-01-07 | Sociedade Unificada Paulista De Ensino Renovado Objetivo - Supero Ltda. | DENTAL ADHESIVE HIGH REACTIVITY RESTAURANT |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2895138B1 (en) | Dental composition | |
JP3303904B2 (en) | Urethane (meth) acrylates containing cyclic carbonate groups | |
US8344041B2 (en) | Monomer for dental compositions | |
ES2597904T3 (en) | Carbamate methacrylate monomers and their use in dental applications | |
JP4490057B2 (en) | Acrylic ester phosphonic acid based dental materials | |
Song et al. | Synthesis and evaluation of novel dental monomer with branched carboxyl acid group | |
Fugolin et al. | Use of (meth) acrylamides as alternative monomers in dental adhesive systems | |
JP2007217447A (en) | Hydroxy group-containing polymerizable compound and method for producing the same | |
Fugolin et al. | Methacrylamide–methacrylate hybrid monomers for dental applications | |
Ahn et al. | Hexaarylbiimidazoles as visible light thiol–ene photoinitiators | |
Barcelos et al. | Effect of the photoinitiator system on the polymerization of secondary methacrylamides of systematically varied structure for dental adhesive applications | |
EP1879544B1 (en) | Materials and dental composites made therefrom | |
US8727775B2 (en) | Dimer acid-derived dimethacrylates and use in dental restorative compositions | |
JP2000204069A (en) | Polymerizably unsaturated bond-containing n-substituted amide compound | |
Fugolin et al. | Synthesis of di-and triacrylamides with tertiary amine cores and their evaluation as monomers in dental adhesive interfaces | |
Park et al. | Enzyme‐catalyzed hydrolysis of dentin adhesives containing a new urethane‐based trimethacrylate monomer | |
US10501562B2 (en) | Co-initiator and co-monomer for use in preparing polymer related compositions, methods of manufacture, and methods of use | |
WO2022178444A1 (en) | Dental adhesives formulated with secondary methacrylamides | |
JP4746440B2 (en) | Fluoroalkyl group-containing chain polymer compound and dental composition containing the same | |
US20200157313A1 (en) | Imidazolium/thiol polymerization initiation system | |
US7560500B2 (en) | Materials leading to improved dental composites and dental composites made therefrom | |
US11712404B2 (en) | Methacrylamide adhesive systems | |
Fugolin et al. | Effect of side-group methylation on the performance of methacrylamides and methacrylates for dentin hybridization | |
Catel et al. | Synthesis of acidic vinylcyclopropanes for dental applications | |
US20240052079A1 (en) | Antibacterial ester-free monomers for dental adhesives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22757130 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22757130 Country of ref document: EP Kind code of ref document: A1 |